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ABSTRACT 
Physical performance is a strong predictor for morbidity and premature death and there is an 
increasing interest in the role of sarcopenia in many chronic diseases. There is a need for 
simple, robust and valid tests for assessing muscle strength and function in clinical practice. A 
novel maximal step-up test (MST) was developed and standardised to fulfil this need.  
The aims of this thesis were to study the repeatability and validity of MST (Study I) and to 
study the associations to age, anthropometric variables, maximal oxygen uptake (VO2 max) 
and self-reported physical function before and after a 3-month group training intervention 
programme (Study II). Furthermore, the aim was to study the long-term effects of the 
intervention programme on maximal step-up height (MSH) after an average of 22 months 
(Study III). 
In Study I, MSH was tested with MST on middle-aged women and men (30/30) with capacity 
to work. 178 female patients were recruited from primary health care for Study II, all of 
whom had joint and muscular problems and most of whom also had reduced capacity to work, 
metabolic risk factors and other chronic diseases. For Study III, 101 out of these female 
patients were recruited. They participated in a 3-month group training intervention 
programme, which included three sessions per week of mixed aerobic fitness and strength 
training. 
The repeatability of MSH between test occasions and between testers was 6 cm in Study I and 
4 cm between testers at 22-month follow-up in Study III. In Study I, MSH was significantly 
correlated to isokinetic knee extension peak torque (r=0.68, p<0.001), self-reported physical 
function (r=0.29, p=0.03) as well as sex, age, weight and body mass index (BMI). MSH 
above 32 cm discriminated subjects with no limitation in self-reported physical function. In 
Study II, at baseline and after the 3-month intervention MSH was negatively correlated to age, 
body weight and waist circumference and positively correlated to self-reported physical 
function, VO2 max and height. MSH correlated to training intensity at follow-up. Changes in 
MSH were significantly correlated to changes in waist circumference and physical function 
regardless of age and changes in VO2 max. MSH below 24 cm discriminated female patients 
with self-reported severe limitation in physical function.  
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The long-term investigation in Study III showed that MSH increased significantly from 27.2 
(5.7) cm at baseline to 29.0 (5.5) cm after three months and thereafter decreased to 25.2 (5.5) 
cm at the long-term follow-up. Time to follow-up (B=-0.42, p<0.001) and change in BMI 
(B=-0.29, p=0.012) correlated significantly to changes in MSH. Waist circumference, VO2 
max, physical function and exercise/physical activity levels were significantly improved at 
long-term follow-up, while BMI did not change. In a univariate logistic regression model, 
maintenance of MSH correlated to the extent of mixed training (OR 3.33, 95% CI 1.25-8.89). 
In a multivariate logistic regression model adjusted for important factors, the correlation was 
not significant. However, MSH was significantly higher in individuals participating in 2-3 
sessions of exercise per week compared to one session.  
In conclusion, the novel maximal step-up test assessing maximal step-up height is considered 
to be a useful and reliable test for leg function in clinical practice. It may also function as an 
indicator of metabolic health. The results of a 3-month group training intervention programme 
with 2-3 sessions per week of mixed aerobic fitness and strength training demonstrated 
increasing maximal step-up height, improved fitness and decreased risk in female patients 
with elevated cardio-metabolic risk. After an average of 22 months without regular group 
training, maximal step-up height was reduced again, while positive effects remained for waist 
circumference, VO2 max, physical function and physical activity. However, regular group 
exercise 2-3 times per week with mixed aerobic fitness and strength training was associated 
with maintenance of maximal step-up height in a subgroup of women. Brisk walking for at 
least 150 minutes per week was not sufficient to maintain maximal step-up height in a 
subgroup of women. 
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SAMMANFATTNING PÅ SVENSKA 
Fysisk förmåga är en stark prediktor för sjuklighet och för tidig död, och det finns ett ökande 
intresse för betydelsen av minskad muskelstyrka (sarkopeni) för uppkomst av kroniska 
sjukdomar. Därför finns det behov av enkla, stabila och pålitliga tester av muskelstyrka och 
benfunktion i klinisk vardag. Ett nytt maximalt klivhöjdstest (maximal step-up test, MST) 
utvecklades och standardiserades med denna intention. 
Syftet med detta avhandlingsarbete var att studera upprepbarheten (repeatability) och 
betydelsen (validiteten) av MST (Studie I) och att studera sambandet mellan den maximala 
klivhöjden (maximal step-up height, MSH) och ålder, kroppsmått (längd, vikt, 
kroppsmasseindex (BMI) och midjemått), maximal syreupptagningsförmåga (VO2-max), typ 
av gruppträning (intensitet), fysisk aktivitet (PA) och självskattad fysisk funktion (formulär 
SF-36, delskalan Physical function (PF)) före och efter ett interventionsprogram med 
gruppträning under tre månader (Studie II). Syftet var också att studera långtidseffekten av 
interventionen på MSH och övriga variabler efter en genomsnittlig tid av 22 månader (Studie 
III). 
I Studie I testades MSH med hjälp av MST på medelålders kvinnor och män (30/30) med 
arbetsförmåga. Till Studie II rekryterades från primärvården 178 kvinnliga patienter med 
besvär i rörelseapparaten samt, i de flesta fall, nedsatt arbetsförmåga, led- och muskelbesvär, 
metabola riskfaktorer och andra kroniska sjukdomar. Till Studie III rekryterades 101 av dessa 
kvinnor. De deltog i ett tre månader långt gruppträningsprogram som innefattade tre pass per 
vecka med kombinerad konditions- och styrketräning. 
Upprepbarheten av MSH mellan testtillfällen och mellan testare var 6 cm i Studie I och 4 cm 
mellan testare vid 22-månadersuppföljningen i Studie III. I Studie I korrelerade MSH till 
maximal isokinetisk knästräckningsförmåga (r=0,68; p<0,001), självskattad fysisk funktion 
(r=0,29; p=0,03) och till kön, ålder, vikt och BMI. MSH över 32 cm kunde urskilja personer 
utan begränsning i självskattad fysisk funktion. I Studie II kunde MSH under 24 cm urskilja 
kvinnliga patienter med minst en uttalad begränsning (SF-36, PF items). Vid studiestarten och 
efter 3 månaders intervention korrelerade MSH negativt till ålder, kroppsvikt och midjemått, 
samt positivt till självskattad fysisk förmåga, kondition (VO2-max) och kroppslängd. MSH 
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korrelerade till träningsintensitet vid uppföljningen. Förändringar i MSH var korrelerade till 
förändringar i midjemått och fysisk funktion oberoende av ålder eller förändringar i VO2-max. 
Långtidsuppföljningen i Studie III visade att MSH ökade från 27,2 (5,7) cm vid studiestart till 
29,0 (5,5) cm efter 3 månader, och sjönk sedan till 25,2 (5,5) cm vid långtidsuppföljningen. 
Tid till långtidsuppföljning (B=-0,42; p<0,001) och förändring i BMI (B=-0,29; p=0,012) 
korrelerade till förändringar i MSH. Midjemått, VO2-max, fysisk förmåga och motions-/fysisk 
aktivitetsnivå var signifikant förbättrade vid långtidsuppföljningen medan BMI var oförändrat 
jämfört med vid start. I en univariat logistisk regressionsmodell korrelerade bibehållandet av 
MSH till antalet pass/vecka med blandad konditions- och styrketräning i grupp (OR 3,33; 
95% CI 1,25-8,89). I en multivariat logistisk regressionsmodell justerad för andra viktiga 
faktorer var korrelationen inte signifikant. Dock var MSH signifikant högre hos individer som 
deltog i 2-3 pass per vecka jämfört med ett pass. 
Sammanfattningsvis anses det nya maximala klivhöjdstestet som mäter maximal klivhöjd vara 
ett användbart och pålitligt test av benfunktion i klinisk vardag. Det fungerar också som en 
indikator för metabol hälsa. Resultaten av ett 3 månader långt gruppträningsprogram med 2-3 
pass per vecka med blandad konditions- och styrketräning visade på ökad maximal klivhöjd, 
ökad kondition och minskad risk hos kvinnliga patienter med ökad risk för hjärt-kärlsjukdom. 
Efter i genomsnitt 22 månader utan regelbunden gruppträning minskade åter den maximala 
klivhöjden, medan positiva effekter kvarstod för midjemått, VO2-max, fysisk funktion och 
fysisk aktivitet. Regelbunden gruppträning med 2-3 pass med omväxlande konditions- och 
styrketräning var kopplat till bibehållen maximal klivhöjd. Enbart raska promenader om minst 
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PREFACE 
My experiences of using physical activity and exercise as treatment in health care have been 
gathered during 35 years of medical work, of which 28 have been spent as a General 
Practitioner at Karolina Primary Health Care Centre in Karlskoga, a provincial Swedish town 
within Region Örebro County with around 30,000 inhabitants. Patients’ aerobic fitness, 
strength and physical function have always been crucial to my clinical examination, choice of 
further investigation, assessment of diagnosis and suggested treatment. Over time, I have 
developed structured prescription of exercise and physical activity. My interest in exercise as 
a means of promoting well-being was established already in adolescence through formative 
experiences of a range of physical activities, outdoor recreation and competitive sport, in my 
case orienteering. This background influenced my interests at Medical School and stimulated 
my early subscription to membership of the Swedish Society for Physical Activity and Sports 
Medicine in 1980. It was also central to my decision to specialise in general medicine, an area 
where sports medicine could be brought to bear on everyday practice, a choice I have never 
regretted!  
As a General Practitioner, I have always worked holistically with my patients, coaching them 
to set and reach individual goals for good health, not only to reduce cardio-metabolic risks, 
but also to help them reach optimal physical function for good health and quality of life. In 
this I drew substantially on my experiences from orienteering, both as an active competitor 
and as one of the doctors for the Swedish national team for twenty years. In these roles, I 
myself experienced that a person is ‘no stronger than the weakest link’, for example, 
physically, mentally or socially: everything needs to be optimised. 
In my medical practice during the 1980s and 1990s, I prescribed recommendations for 
exercise for increased aerobic fitness, strength, health and quality of life at an evening health 
centre and also at an evening sports medicine centre, to which patients came on their own 
initiative. In my capacity as a medical doctor, I was able to answer questions and offer advice 
on how patients could plan and carry out exercise based on their needs and desires, while 
being mindful of former overuse or acute injuries and chronic diseases, other health risks and 
medication. The patients who came, either on the advice of medical staff or after their own 
researches, were already committed to exercise. They wanted to know their fitness level, how 
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to initiate or restart exercise while suffering with, for instance, osteoarthritis, how to reduce 
the risk of overuse injuries or how to lose weight.  
When medical practitioners tried to encourage suitable patients at my Primary Health Care 
Centre to visit the evening health centre instead, it was very difficult to persuade patients with 
a diagnosis or those who had no or reduced capacity to work to go there. The hardest group to 
motivate was those patients who described that they ‘did not feel well’. This group consisted 
primarily of women as two thirds of patients coming to primary health care are women. This 
situation gave me the idea and impetus to start the MABRA project – a new kind of group 
training programme in primary health care for both treatment and prevention of common 
diseases and disorders – focusing on precisely these kinds of patients in our daily clinical 
practice.  
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LIST OF ABBREVIATIONS 
BMI   Body mass index 
BOA A supportive osteoarthritis self-management programme and register 
(Better management of patients with OsteoArthritis) 
BP   Bodily pain (SF-36, subscale) 
CI   Confidence interval 
COPD  Chronic obstructive pulmonary disease 
CVD   Cardiovascular disease 
FaR®   Fysisk aktivitet på recept (PAP) 
GH   General health (SF-36, subscale) 
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HOOS  Hip disability and Osteoarthritis Outcome Score 
ITT   Intention to treat 
IKEPT  Isokinetic Knee Extension Peak Torque 
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MABRA  MÅ BRA project the name in the Swedish language   
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MET     Metabolic equivalent  
MetS   Metabolic syndrome 
MST   Maximal step-up test 
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OR   Odds ratio 
PA   Physical activity 
PAP   Physical Activity on Prescription (FaR®) 
PE   Physical Education 
PF   Physical function (SF-36, subscale) 
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T1   Measurements at 3-month follow-up 
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T2D   Type 2 diabetes 
VO2 max  Maximal oxygen consumption 
VT   Vitality (SF-36, subscale) 
WC   Waist circumference 
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1.1 INTRODUCTION – PRIMARY HEALTH CARE 
In primary health care I have often encountered patients who, when asked, assess their level 
of aerobic fitness as low and who feel insufficiently strong. For these patients, this has often 
been their level of fitness and strength for many years. Research in the general field of 
physical activity and health is extensive. What is still missing, however, is research on how 
the new understanding brought by this research could be implemented in practice. Yet there is 
a lack of studies of established routine tests in clinical everyday practice of leg muscle 
strength and physical function. The need for assessment is much greater than a well-
functioning physiotherapy service could reasonably manage. Because of the pressing need for 
large numbers of patients to be tested on leg muscle strength and leg function, and because 
the results from these tests – which are perishable goods – are needed at the very moment 
when a patient visits her or his GP or nurse, we need to find new and simple tests and 
routines.  
Since primary health care has a central function when assessing, investigating and treating 
patients’ health as a whole, it is of great significance that these studies of practical 
implementation and testing of physical function ought to start in primary health care. In Study 
I presented below, a novel test for assessing leg muscle strength and leg function – maximal 
step-up test (MST) – is introduced, that would be easy and quick to use by GPs, nurses and 
physiotherapists in everyday clinical practice [1]. 
General practice differs between national contexts. In Sweden today, it is common with an 
integrated form of practice where GPs, nurses, physiotherapists and other health professionals 
work as teams around a range of areas of expertise. Some examples of areas where 
prescription of physical activity as treatment and prevention (PAP, FaR®) are recommended 
according to the latest research (www.fyss.se/FYSS 2015) are cardiovascular disease/lifestyle, 
type 2 diabetes (T2D), chronic obstructive pulmonary disease (COPD) and symptomatic 
osteoarthritis (OA). One significant advantage of locating an intervention programme within 
primary health care – which was the case with the MABRA project described in this thesis in 
Studies II and III – is that it can be designed from the holistic perspective that the GP is 
afforded, knowing the full and varied history of each of her patients [2]. This understanding 
of the patient as a whole is also helpful when encouraging and supporting participation in 
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such a project. In addition, GPs and teams of health care professionals in primary health care 
support their patients by offering continuity and coherence within a health care sector that is 
becoming increasingly specialised and fragmented. 
1.2 WHY STUDIES ON WOMEN? 
Stories of tiredness and a difficulty to cope with both work and looking after the home are 
common when we meet working-age women. A relevant question to ask in these cases is to 
what extent this experience may be due to low levels of aerobic fitness and low muscle 
strength. If the physical capacity is deemed to be low in one or both of these ways, the follow-
up questions ought to be about what other potential consequences there may be of reduced 
fitness and strength, such as increased cardio-metabolic risk. These questions are especially 
important when a reduced capacity to work results in sick leave with cessation of 
transportation to work and reduced everyday activity: in sum, increased sedentary behaviour.  
Studies have shown that women visit primary health care more often than men and it seems to 
be associated with their higher morbidity burden. The interaction between biology and 
socially constructed roles could also underlie this higher use by women, and is therefore an 
area that deserves further in-depth research [3]. There is also research to suggest that women 
still, on average, take greater responsibility for the practical running of the home and for 
childcare than men [4]. The majority of previous studies of physical function and health has 
most often been focused exclusively on men. For reasons of equality and democracy not least, 
there is thus an urgent need for studies of women’s physical function in relation to poor 
health, and of the most effective methods of treatment of low aerobic fitness and low muscle 
strength. These principles make up the background for the planning and implementation of 
the 3-month intervention programme from which data from a female population of patients 
aged between 22 and 83 have been gathered. Data collected at registration and at the end of 
the programme have been analysed in Study II, whereas data from the long-term follow-up at 
a median of 22 months form the basis of Study III.  
1.3 KARLSKOGA MABRA PROJECT – A PRACTICAL TRAINING 
PROGRAMME FOR PATIENTS IN PRIMARY HEALTH CARE 
The MABRA project was set up in the Swedish provincial town of Karlskoga to care for 
patients with a range of common diseases and illnesses for whom intervention with physical 
exercise was deemed beneficial for improved general health and well-being. As outlined in 
the Preface, the stimulus came from a felt need to support patients who required active 
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intervention from health care professionals to start and maintain regular physical exercise at 
low, moderate or high intensity. The project consisted of a 3-month intervention programme 
in which patients committed to exercising in groups three times per week. Data from this 
project were used in Studies II and III. The principles and objectives for the MABRA project 
described below were discussed and agreed within the project team before the start of the 
project and then followed throughout.  
Funding for the Karlskoga MABRA project came from Region Örebro County, the Swedish 
National Institute of Public Health (Folkhälsomyndigheten), Karlskoga Municipality, the 
Swedish Social Insurance Agency in Karlskoga (Försäkringskassan) and the Karlskoga Job 
Centre (Arbetsförmedlingen), all in Sweden. 
1.3.1 Key objectives 
One key objective for the project was to introduce patients to different forms of exercise by 
which to improve aerobic fitness and muscle strength, as treatment and for reducing cardio-
metabolic risks. Another main objective was that the sum total of care throughout the 
intervention programme would improve patients’ capacity to work.  
1.3.2 Forms of exercise 
A varied range of group activities was offered to maintain high engagement and participation. 
The forms of group exercise available mostly consisted of mixed aerobic fitness and strength 
training, such as circuit training, spinning, aqua aerobics and Nordic walking on forest tracks. 
Dance and movement therapy was chosen by patients with specific needs, most often 
psychiatric illnesses, in order to facilitate participation in group exercise. Qigong was chosen 
by patients suffering from stress or with chronic pain or fibromyalgia. Medical advice was 
available at every session. All patients were offered an individually tailored programme of 
self-selected group exercise, discussed with medical support at registration, which could be 
revised after tests and during the first two weeks of the programme if necessary. 
Particular emphasis was placed on teaching patients to improve leg muscle strength in 
everyday life; for instance, by choosing the stairs rather than the lift or by using step-up 
boards at the gym with the same technique as used for the maximal step-up test. 
1.3.3 Engagement and motivation 
Great care was taken when selecting members of the project team to ensure that their attitude 
would engender increased confidence and well-being in patients. The members of the project 
team shared a keen awareness of the importance of the attitude communicated to patients and 
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worked to create an environment in which exercise became enjoyable. For example, they used 
music to stimulate and engage patients and provided a positive atmosphere with plenty of 
encouragement and support. There was no discussion of illness or health care during the 
scheduled exercise.  
Patients were asked to commit to exercising three times a week for three months in order to 
be admitted to the project. This requirement was included to ensure a sufficient level of 
motivation to carry out the intervention programme.  
1.3.4 Accessibility and equality of care 
Offering accessibility and equality of care was another core principle. The project was open to 
patients of both sexes, over the age of nineteen, with common diseases and illnesses. All 
exercise sessions during the 3-month intervention programme were free of charge for patients 
to ensure equal access. Accessibility was also promoted by organising group exercise in a 
large number of different locations across the town.  
Short waiting times for taking up a place in an exercise group were guaranteed throughout. 
Flexible groups were created so that patients could begin group exercise straight at the point 
of inclusion in the project and new groups were started when needed. To make this possible, 
collaboration was initiated with local gyms and public health units. The optimal total number 
of patients within group activities at any one time was around 75 for the size of the project 
team in question, described in 1.3.5. At that level, each patient could be fully cared for. At its 
most extensive, there were around 130 patients participating in group exercise in parallel.  
An intention within the project team right from the start was that the experience of regular 
physical exercise would encourage patients to maintain a sufficient level of physical activity 
long-term. At the end of the programme, patients were systematically referred to group 
exercise or individual exercise by a nurse. They were asked to report on their progress to their 
GP. These follow-on groups are today, after more than fifteen years since the start of the first 
groups, still on-going and led by instructors at local gyms or public health units who have 
been trained by the project team in supporting continuing exercise for these patients. 
Due to a lack of resources for translation and interpretation it was not possible to include 
participants without a working knowledge of the Swedish language in the project.  




1.3.5 Organisation of the project  
The project team consisted of a project leader (GP) and four other members: a nurse as project 
coordinator; a nurse with a degree in Dance and Movement Therapy who took up the role as 
project coordinator later on in the project; and two certified exercise instructors who were also 
certified testers. The main tester had six years of experience from medical rehabilitation work. 
The project coordinator had over thirty years of experience as a nurse in clinical practice and 
primary health care and several years of experience of teaching nursing students at tertiary 
level. The members of the project team were carefully selected for their experience, skills and 
attitude. The practical organisation of the work within the project team was democratic and 
non-hierarchical.  
The reason for hiring exercise instructors and testers as part of the project team was the high 
workload of physiotherapists employed at local primary health care centres, without room in 
their schedules for the level of involvement required by the project. However, 
physiotherapists at patients’ local primary health care centres were consulted when support 
was needed on the level of an individual patient.  
Medical care and consultation about sick leave were offered to patients by their ordinary GPs 
throughout the project. 
1.3.6 The project team 
The project leader (GP) 
• offered medical advice and support at team meetings every week 
• kept in touch with health care centres and units, local authorities and public agencies 
such as the Swedish Social Insurance Agency (Försäkringskassan) and the Job Centre 
(Arbetsförmedlingen) 
• was responsible for producing material for collection of data 
• continuously reported on findings to funding bodies 
• had regular contact with doctoral supervisors at research centres and departments at 
Swedish and international universities 
• contacted researchers for support with evaluation of results within health economic 
• communicated with ethical committees 
• applied for funding 
	   	   	  
	  
6 
The project coordinator (nurse) 
• registered all patients at inclusion in the project 
• acted as the patients’ medical coordinator 
• conducted a structured interview of one and a half to two hours at the start of the 
project which included  
o constructing a health profile based on patient questionnaire 
o discussion of potential interference of medical problems, social functionality and 
lifestyle with the exercise programme 
o measuring the patient’s weight, height, BMI and waist circumference 
• recorded self-assessed quality of life at start and follow-ups, especially with respect to 
physical function (SF-36) 
• organised an obligatory talk by a nurse from the local public health unit to patients, 
giving them a basic understanding of the impact of diet on the effects of exercise 
Testers and exercise instructors 
• measured leg strength with maximal step-up test at start of project and at follow-up 
after the 3-month intervention programme and long-term; 
• tested aerobic fitness with submaximal cycle test at start and follow-ups; 
• planned and ran group exercise at appropriate levels; 
• organised an obligatory talk by a physiotherapist on basic exercise physiology for 
patients with locomotor problems and prevention of acute and overuse injuries; 
• arranged for physiotherapists to design appropriate programmes of strength training for 
patients with shoulder, neck/back, hip or knee problems; 
• used the Borg RPE Scale for intensity control at each exercise session and taught 
patients to use it for themselves for the future; 
• ensured that the pace of the music accompanying each exercise session set the level of 
intensity, low, moderate or high (Borg 9-11, 12-13 and 14-15). 
The use of step-counting devices was discussed, but at time of the intervention programme 
this technology was comparatively premature and such measuring would have been 
logistically challenging to arrange at the time. 
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1.4 PHYSICAL ACTIVITY , AEROBIC FITNESS, MUSCLE STRENGTH AND 
HEALTH – CARDIO-METABOLIC RISKS 
Numerous studies have shown a strong correlation between physical activity and health [5, 6] 
and both aerobic fitness and physical activity are independently associated with lower 
cardiovascular risk [7, 8]. Low aerobic fitness is an important predictor of mortality especially 
among women [9]. Notably, our study of female patients showed that VO2 max at baseline 
was low compared to that of healthy women in other studies [10, 11]. Hakola et al. have 
shown that the number of chronic diseases was inversely associated with VO2 max [11]. 
Furthermore, physical work capacity declines with age due to decreases in aerobic and 
musculoskeletal capacity.  
A strong correlation has been shown between the degree of physical activity and premature 
death [9, 12-14], cardiovascular disease (CVD), type 2 diabetes (T2D) [15], colon and breast 
cancer, osteoporosis, symptomatic osteoarthritis (OA), asthma/COPD, depression and 
dementia. There is also a strong correlation between weak muscular strength and a high 
prevalence of obesity and metabolic syndrome (MetS) [16], premature death [17-19] and 
cancer [20]. Moreover, the assessment of	  the functional capability can help to determine the 
degree of physical decline in persons with MetS [16]. A large population-based study from 17 
countries – which was run	  for four years with nearly 140 000 individuals (58% women) with 
median age 50 (42-58) years and with varying income and sociocultural background – 
showed that grip strength was a stronger predictor of cardiovascular and all-cause mortality 
than systolic blood pressure [21]. Knowledge about identified associations between 
psychological symptoms and common physical functions [22] – for example, reduced leg 
muscle strength – is important in prevention and treatment of our common diseases and	  
disorders. 
Assessment of physical activity, fitness, muscle strength and physical function is of great 
importance in clinical practice for diagnosis, treatment and follow-up of individuals at risk 
for, for instance, CVD and metabolic disease [7, 9, 23-25], symptomatic OA [26] the 
chronically ill [27] and patients with limited physical working capacity [28, 29]. Furthermore, 
objectively assessed physical performance – such as low maximal oxygen uptake [7, 9, 30] or 
low muscle strength [31, 32] – is a strong predictor of morbidity and premature death 
independently of physical activity and muscle mass. Interestingly, in men <60 years of age the 
rate of loss of strength has been shown to be more important than actual strength [33]. Muscle 
strength also provides a better estimate of mortality risk than does muscle quantity [34].  
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Recent evidence-based recommendations include endurance as well as resistance training [6] 
for health benefits. Loss of muscle mass and knee extensor strength correlates with an 
increased risk of falling and loss of functional independence, and has been identified as the 
most important factor limiting the ability to get up from a chair [35]. A primary risk factor for 
knee pain is quadriceps muscle weakness, disability and progression of joint damage in 
persons with OA of the knee [36], one of the most common medical conditions from middle 
age onwards [36, 37].  
There is therefore a need in clinical practice for simple, robust and specific tests of leg 
strength and leg function to provide clinically relevant measures that reflect overall health. 
However, the tests recommended to date have several shortcomings. First, many tests – for 
example, walking tests – do not capture muscle strength per se but rather a combination of 
muscle strength and aerobic capacity. Second, robust standardisation of the performance test 
procedure is rare. Third, few tests allow discrimination between the two legs. Fourth, the vast 
majority of tests have been validated for elderly populations only. In a review of published 
studies that tested the validity and reliability of fall-risk assessment tools, few tools were 
tested more than once or in more than one setting [38] and the authors did not recommend a 
single tool for implementation.  
1.5 OSTEOARTHRITIS – EXERCISE RECOMMENDED AS THE FIRST LINE OF 
TREATMENT  
Early clinical diagnosis of chronic knee and hip osteoarthritis (OA) is important for 
prevention and treatment	  [26, 39]. A physiotherapist diagnoses clinical osteoarthritis using 
national guidelines in the context of patients’ needs, providing information, supervised 
exercise, self-administered tests for strength and aerobic fitness, lifelong physical activity on 
prescription and a collaborative approach to dealing with weight loss [39].  
It is important to treat risk factors for cardiovascular disease and premature death. 
Osteoarthritis in knee and hip reduces patients’ physical activity, strength and fitness, and 
increases sedentary behaviour. A better understanding of sarcopenia helps practitioners 
identify implications for patients with OA [40]. Today one of the recommended assessments 
of leg function for OA patients is a 30-second sit to stand test [41]. Together with a test of 
controlled knee bending useful in clinical practice – for example, ‘pick up a pencil from the 
floor using knee bending’ – these tests could be used by all health care staff and also be 
suitable for self-testing.  
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From studies we know that patients with early symptomatic osteoarthritis showed worse 
functional capacity and self-reported health compared to healthy ageing workers. Patients 
with early symptomatic osteoarthritis of the hips and knees participated in the 3-month 
intervention programme in the Karlskoga MABRA project. In a study, a substantial 
proportion of female subjects with osteoarthritis reported worse mental health status in SF-36 
than their male counterparts [42]. Also, when subjects with early symptomatic osteoarthritis 
of the hips and knees were studied, many female subjects did not meet physical job demands 
as was the case for many female patients with reduced leg muscle strength and function in 
Study II and III of this thesis [42].  
In another study, information about a person’s functional capacity to work was found to have 
complementary value for assessment of physical capacity to work [43], and also changed the 
judgments of the medical professional [44]. Testing of functional capacities together with 
self-reported physical function and health is widely used to discriminate potential patients 
from healthy persons, and to describe aspects where the patients do not meet physical job 
demands. In patients with hip and knee OA undergoing surgery, performance-based 
functional outcome tools give additional information to the patient’s report in Hip disability 
and Osteoarthritis Outcome Score (HOOS) and Knee injury and Osteoarthritis Outcome Score 
(KOOS) questionnaires. This will reduce difficulties in distinguishing between pain and 
function and will reduce floor and ceiling effects [45, 46]. Compared to preoperatively, a 
significant improvement in KOOS was still seen 5 years postoperatively, the best result was 
reported at 1 year, indicating a decline from 1 to 5 years after total knee surgery. To fully 
evaluate the results with regard to pain and PF, follow-ups after more than 2 years were 
recommended [47]. MST could be a useful test of leg strength and function as a complement 
to HOOS and KOOS questionnaires for patients undergoing OA joint replacement surgery 
and future research is recommended. Moreover, research on the usefulness of MST as a tool 
for prescription of physical activity for patients with OA in hip and knee and for long-term 
follow-ups is also recommended.   
Exercise is recommended as first-line treatment of degenerative knee disease. Today in 
primary health care in Sweden, patients with OA in hip and knee are invited to a supportive 
osteoarthritis self-management programme called BOA (Better management of patients with 
OsteoArthritis). The self-management programme converts the scientific evidence on how 
best to train the arthritic hip and knee into clinical practice. The supportive osteoarthritis self-
management programme is always led by a physiotherapist, often in collaboration with an 
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occupational therapist and an osteoarthritis communicator. The knowledge transferred from 
scientific research to medical professionals and then onto patients enables patients to make 
decisions about personal health and changes in lifestyle for better health. The BOA register 
has existed as a National Quality Register for physiotherapists in Sweden since December 
2010, www.boaregistret.se. 
A supportive osteoarthritis self-management programme can reduce self-reported hip [48, 49] 
and knee pain and increase self-reported quality of life. OA patients ranging from mild to 
advanced symptomatic OA took part in the MABRA intervention programme studied in this 
thesis. They have been assessed with repeated MST and our experiences from these patients 
are good with no major side effects reported when assessing according to standardisation. 
MST addresses many components in neuromuscular exercise, targeting more closely the 
sensorimotor deficiencies and functional instability associated with the degenerative knee 
disease than traditionally used training methods	  [50].  
Today’s guidelines for clinical diagnosis of OA in knee and hip are shown in Figures 1 and 2.  
Figure 1. Clinical diagnosis of osteoarthritis of the knee  
• Anamnesis (risk factors): age, gender, overweight, previous joint injury, overuse at 
work or at home and heredity. 
• Symptoms: pain at straining of the knee, reduced functionality and stiffness in the 
morning. 
• Clinical findings at examination of the joint: crepitation, reduced mobility and 
widened joint. 
• When three symptoms and only one or two clinical finds are present a less serious 
level of osteoarthritis is indicated. 
 Guidelines on osteoarthritis from the National Board of Health and Welfare, 2012 
Reproduced with permission from Läkartidningen [39]. 
 




Figure 2. Clinical diagnosis of osteoarthritis of the hip 
• Anamnesis (risk factors): age, gender, overweight, previous joint injury, overuse at 
work or at home and heredity. 
• Symptoms: pain in the hip, stiffness after inactivity and reduced functionality. 
• Clinical findings at examination of the joint: reduced flexion, inward rotation and 
pain at inward rotation.  
• Several typical symptoms and clinical findings need to be present for a high diagnostic 
value. 
Guidelines on osteoarthritis from the National Board of Health and Welfare, 2012 
Reproduced with permission from Läkartidningen [39]. 
1.6 DEFINITIONS OF PHYSICAL ACTIVITY 
The definitions of physical activity and related terms in this section have been translated and 
reworked from the 2015 edition of FYSS (Physical activity in the prevention and treatment of 
disease, www.fyss.se). FYSS has been written, and is continuously updated, on behalf of the 
Professional Associations for Physical Activity (YFA) in Sweden and funded by the The 
Public Health Agency of Sweden (Folkhälsomyndigheten). Reproduced with permission from 
YFA. 
Physical activity is characterised by complex behaviour. It is defined, in physiological terms, 
as all movement of the body that increases the consumption of energy above and beyond the 
energy we consume at rest. Physical activity may occur at home, at work, during 
transportation from one place to another, in one’s free time and in the form of organised 
exercise. Physical inactivity thus consists of an absence movement; that is to say, close to the 
consumption of energy we experience at rest. In some studies, physical inactivity is used as a 
classification to describe persons who do not fulfil the recommendations for level of physical 
activity. In FYSS, persons who do not fulfil these recommendations are described as 
‘inadequately physically active’. In Sweden, the concept of sedentary is also used to describe 
inactivity. A day consists of a mixture of types of inactive behaviour (lying down, sitting, 
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standing) and different types and degrees of physical activity (bodily movement at low to very 
high intensity).  
A person who is physically active at moderate intensity for 150 minutes per week is classified 
as ‘sufficiently physically active’. That phrase, however, does not say anything about the level 
of activity during the remaining waking hours. That means that it would be possible for a 
person to be described as, at once, ‘highly active’ and ‘sedentary’. Aerobic physical activity, 
the most common form of physical activity, is characterised by the need for energy, in the 
first instance, being covered by processes that expend oxygen. The intensity may be low, 
moderate or high. The general guidelines suggest that the recommended dosage of physical 
activity (at least 150 minutes per week) ought to be aerobic in character, and that the intensity 
ought to be at least at moderate level to lead to positive health effects. Aerobic fitness training 
is a form of aerobic physical activity with the purpose to maintain or improve fitness. The 
intensity could be at a moderate, high or very high level. Strength training is a form of 
physical activity where the intention, in the first instance, is to maintain or increase different 
forms of muscular strength (for instance, maximal power, explosiveness and/or muscular 
stamina) and to maintain or increase muscle mass.  
1.6.1 Intensity – absolute and relative 
Intensity describes the level of strenuousness at which physical activity is carried out. It is 
normally divided into several levels from very low to very high. Moderate intensity is 
characterised by an increase of pulse and frequency of breathing. High intensity means a 
marked increase in pulse and frequency of breathing, while very high intensity means 
maximal levels of pulse and frequency of breathing with anaerobic use of energy as a 
consequence, such as the formation of lactic acid. Intensity may be expressed as absolute or 
relative. The strenuousness at muscle-strengthening activities may be given as absolute 
intensity in relation to a person’s maximal ability (% 1RM=maximal strenuousness at 
repetition). Intensity can also be assessed as experienced exertion with the help of different 
scales, such as Borg’s RPE scale. Such self-assessed exertion is an expression of relative 
intensity [51]. 
An individual’s consumption of energy at rest is used to assess the energy use for a specific 
activity or for a day. The energy consumption of the specific activity or day is expressed as a 
multiple of the energy used at rest. The expression metabolic equivalent (MET) is used as 
shorthand. Energy consumption at rest is the equivalent of 1 MET. Energy consumption 
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during a brisk walk, for instance, is assumed to be four times as high as at rest and is thus 
expressed as 4 METs. As an estimate, it is generally calculated that 1 MET is the equivalent 
of an oxygen consumption of 3.5 ml per kg of body weight and minute, or as an energy 
consumption of 1 kcal per kg of body weight and hour. These models for conversion are used 
when uptake of oxygen or energy consumption per unit of time are calculated based on 
METs. MET minutes or MET hours are concepts used to describe total energy consumption 
across time. 
1.7 SELF-REPORTED HEALTH WITH FOCUS ON PHYSICAL FUNCTION 
The Short Form (36) Health Survey, more commonly known as SF-36, is a patient-reported 
questionnaire for assessing patient health. It has been designed as a general indicator of 
patient health for use in population studies and evaluative studies of interventions for 
improving health. As a tool, it can also be used together with tests for specific diseases in 
clinical research. It is a self-instructing questionnaire which takes 5-10 minutes to fill out and 
presents eight dimensions of self-assessed health: vitality, physical functioning, bodily pain, 
general health perceptions, physical role functioning, emotional role functioning, social role 
functioning and mental health. The different dimensions cannot be summarised as one. 
Instead results are reported in the form of health profiles consisting of eight different scores.  
When used on persons of good health who increase their level of physical activity, the SF-36 
scores on physical functioning and mental health may be too low for recorded improvements 
of health to be significant. The highest score for physical functioning corresponds to the most 
basic capacity for participating in any form of strenuous activity such as running or lifting 
something heavy. It is common for the SF-36 questionnaire to be used at rehabilitation of 
particular groups and when studying physical activity in elderly populations. The 
questionnaire is one of the most frequently used tests in Sweden today and there is a Swedish 
translation which is commonly used [52]. 
Two thirds of the patients in the project were on temporary part-time or full disability pension 
or sick leave at the time of referral. They had low scores on the SF-36 physical scales and also 
low scores for mental health. In the Swedish norming population [53], low scores in SF-36 
were associated with women, social risk factors such as disability pension and unemployment, 
reduced physical functioning and increased bodily pain. Physical function scores were 
strongly associated with age, whereas there were only small differences in the mental health 
scales across age groups [53]. 
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The aims of this thesis were to study the repeatability and validity of MST (Study I) and to 
study the associations to age, anthropometric variables, maximal oxygen uptake (VO2 max), 
and self-reported physical function before and after a 3-month group training intervention 
programme (Study II). Furthermore, the aim was to study the long-term effects of the 
intervention programme on MSH after a mean of 22 months (Study III). 
2.1 STUDY I    
The aims were to evaluate a novel method for measurement of lower-extremity function, the 
standardised maximal step-up test (MST), by assessing maximal step-up height (MSH) 
repeatability and MSH relation to leg muscle strength assessed as isokinetic knee extension 
peak torque (IKEPT), in relation to health-related quality of life (SF-36, subscales for 
physical function (PF), bodily pain (BP) and general health (GH)), individual characteristics 
and self-reported physical activity (the International Physical Activity Questionnaires, IPAQ, 
short form) and MSH cut-off for any limitations in physical function (SF-36, PF score and 
summary of selected item responses).  
2.2 STUDY II    
The aims were to investigate – in a female patient population with common diseases, elevated 
cardio-metabolic risk, musculoskeletal pain and reduced capacity to work – the associations 
between maximal step-up height (MSH) and age, anthropometric variables, maximal oxygen 
uptake (VO2 max) and physical function as well as the effects of a 3-month group exercise 
intervention on MSH. 
2.3 STUDY III    
The aim was to investigate – in a female patient population with common diseases, elevated 
cardio-metabolic risk, musculoskeletal pain and reduced capacity to work – the long-term 
effects of a 3-month group exercise intervention on MSH, cardio-metabolic risk factors and 
physical function. Furthermore, we studied factors associated with long-term effects on MSH 
in the whole study population, in subgroups of patients of different ages, as well as in 
subgroups with high, moderate or low maintenance of MSH. 




3 MATERIALS AND METHODS 
3.1 DESIGN 
3.1.1 Study I  
Subjects were invited in groups of ten to two test occasions (occ 1 and occ 2), one week apart, 
for intra-tester assessment of MSH test-retest repeatability. Four weeks after occ 1, the 
participants came individually to the third test occasion (occ 3) for assessment of IKEPT and 
MSH test-retest repeatability (comparing occ 1 and occ 3). At occ 1 and occ 2, MSH was 
assessed twice at least 30 minutes apart by two testers – the first author and a tester 
accustomed to the MST – in random order for assessment of inter-tester test-retest 
repeatability. MSH of both legs was assessed with the MST on all three occasions.  
The MST values remained secret between testers and occasions, and the subjects agreed not 
to inform the tester of earlier results. Weight and height were measured at occ 1, and weight 
at occ 3. The SF-36 was assessed at occ 1. Physical activity levels during the week between 
occ 1 and occ 2 and the week before occ 3 were assessed. The subjects were instructed to 
maintain their ordinary physical activity habits during the study. At occ 3 all subjects began 
with an MST conducted by the first author. 30 minutes after the test, IKEPT was measured by 
a physiotherapist well acquainted with the procedure.  
3.1.2 Studies II and III 
214 female patients were recruited consecutively over an 18-month period, through referrals 
from primary health care, to an on-going 3-month intervention programme with group 
exercise three times per week (Karlskoga MABRA project). The patients’ ability and 
willingness to take part in the project were documented. Data were collected at baseline and 
immediately after the 3-month intervention. Out of the 214 female patients, 178 attended the 
test at baseline (T0) and 156 of those participated in the 3-month intervention programme and 
took part in a second assessment (T1) [2]. Out of these 156 patients, 114 were randomly 
invited for a third assessment (T2), out of whom 101 agreed to participate (89% response 
rate). The reasons not to attend the long-term follow-up were diverse, see Figure 3. 




Figure 3. Flowchart describing the inclusion, sample sizes and drop-out numbers  
 
178 patients (83% response rate) were included out of 214 female patients referred to the 3-
month intervention programme. The reasons for not attending were diverse. 
3.2 STUDY POPULATIONS 
3.2.1 Study I  
The inclusion criteria were: 1) female or male, 2) 30-65 years old, 3) no self-reported 
complaints associated with legs or hips leading to a visit to a health care unit within the 
previous six months, 4) no major health problems that interfered with climbing stairs, 5) from 
inactive to regularly physically active, 6) never before having been tested with a step-up test, 
climbing test or on an isokinetic device, 7) well motivated, and 8) have working knowledge of 
the Swedish language. Invitations were distributed to a number of workplaces, a men’s 
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running group and their partners. 30 women and 30 men with a median (range) age of 53 (34-
63) and 55 (36-64) years respectively were enrolled. All female and male subjects were in 
employment and came from about 20 different workplaces respectively. They represented a 
wide variety of professions and educational backgrounds.  
3.2.2 Studies II and III 
The inclusion criteria were: 1) voluntarily seeking primary care for a common complaint or 
disease related to the musculoskeletal system, obesity, cardiovascular disease, diabetes, 
asthma/chronic obstructive pulmonary disease (COPD), mental disorders (that is, depression, 
anxiety, stress related symptoms, sleep disturbances, burn-out syndrome and fibromyalgia), 
and/or other chronic diseases against which increased physical activity was deemed likely to 
be beneficial, 2) aged 19 years or over, 3) sufficiently motivated and willing to accept group 
training three times per week for three months, 4) able to take part in group training without 
personal assistance, 5) able to transport herself independently to and from the exercise 
activities, and 6) have working knowledge of the Swedish language.  
Half of the 178 female patients included had upper secondary school as their highest level of 
education; one third had been to university or college. Most of the patients (72%) were 
married or co-habiting. A majority (66%) was on sick leave or had part-time or full temporary 
disability pension. 16% were working despite medical problems. 5% were working and were 
allowed two hours three times per week of exercise as illness-prevention or rehabilitation with 
financial support from the Swedish Social Insurance Agency (Försäkringskassan). 10% had old-
age pension and 3% were looking for a new job and receiving job seekers’ allowance.  
The main chronic diseases, psychosocial conditions, illnesses and complaints in the 
musculoskeletal system (symptomatic osteoarthritis was common), were diagnosed and 
documented by the referring GP on the standardised referral documents. Medications were 
reported by the referring GP and confirmed by the patient at inclusion. Over two thirds (71%) 
of all 178 patients were taking analgesics. 88 (49%) of the patients had at least one of the 
psychosocial conditions diagnosed in primary health care – depression, anxiety, stress-related 
problems, sleep disturbance, burn-out syndrome or fibromyalgia – and 49 (56%) of these 88 
patients were taking medication for these indications. Daily smoking was reported by 26%. 
No significant difference in baseline measurements between the 101 participating patients and 
the remaining 77 were found regarding anthropometry, education, sick leave, self-reported 
pain and/or reduced physical function. However, age differed significantly, with a higher 
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mean age in the 101 participants compared to the 77 who did not participate in T2 (mean 52 
years versus 47 years, p=0.003). 
3.3 ETHICAL APPROVAL 
Written informed consent was obtained from all participants after oral and written information 
about the studies had been provided. The local ethics committee at Örebro County Council 
approved all procedures for all three studies.  
3.4 MEASUREMENTS 
3.4.1 Patient characteristics 
Height was measured without shoes to the nearest 0.5 cm using a scale fixed to the wall. Body 
weight was measured in light clothing without shoes to the nearest 0.1 kg using electronic 
scales (Seca Delta model 707). Body mass index (BMI) was calculated according to the 
standard formula (kg·m-2). In Studies II and III waist circumference (cm) was assessed at the 
level of the umbilicus according to standard practice. 
3.4.2 Isokinetic knee extensor peak torque 
IKEPT (N·m, 60°·sec-1), essentially reflecting maximal concentric quadriceps strength, was 
assessed in an isokinetic dynamometer (Biodex System III PRO, Biodex Medical System, 
New York, NY, USA) due to standard praxis (Study I).  
3.4.3 Aerobic fitness – Åstrand’s submaximal test on oxygen consumption 
In Studies II and III the VO2 max was estimated as described by Åstrand [54] from each 
participant’s individual heart rate response to a given sub maximal workload (that is, 50-150 
W, depending on the participant’s weight and self-reported physical activity) using a bicycle 
ergometer (Monark, Varberg, Sweden) recorded at a steady state of heart rate (120-150 
beats·min-1), and quantified as peak absolute oxygen consumption per minute (L·min-1) and 
per kg body weight per minute (mL·kg-1·min-1).  
3.4.4 SF-36 physical function score 
To assess self-reported health-related quality of life, the Swedish version of the SF-36 was 
used [52]. Patients filled out the forms in advance and at the visit assistance was given when 
needed as directed in the manual. All raw scores were transposed onto scores on a weighted 
0-100 scale, higher scores representing better health status [55]. The subscales physical 
function (PF), bodily pain (BP) and general health (GH), all with a strong correlation to age 
[53], were used to describe subjects in Study I. All eight subscales were used in Studies II and 
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III, and compared with the general Swedish population. The subscale PF was extracted for 
further item analyses. A selection of items 3a, 3b, 3d, 3f and 3g, assumed by the authors in 
this study to be suitable for assessment of subjects with capacity to work, were used for 
comparison with the first assessment of MSH (mean of right and left leg) at occ 1 in Study I. 
A selection of items 3b, 3d, 3f and 3g, assumed suitable for assessment of patients, were used 
for comparison with all assessments of MSH (mean of right and left leg) in Studies II and III.  
This scale was also used to investigate whether any MSH score cut-off level identified 
subjects in Study I with any limitation (score <100), and in Study II with severe limitation in 
physical function.  
3.4.5 Physical activity 
A locally adapted version of the self-administered International Physical Activity 
Questionnaire (IPAQ), ‘the last 7 days short form questionnaire’ [56], was used for assessing 
self-reported physical activity (min·wk-1) in Study I. Energy expenditure (kcal·wk-1) was 
calculated according to MET (Metabolic Equivalent) estimates [57]. Mean energy expenditure 
from reported vigorous and moderate activity and strength training time over a two-week 
period were used. 
3.4.6 Self-reported exercise and physical activity levels  
Exercise and other physical activity were assessed at baseline (Studies II and III) and at the 
third assessment (Study III) with a validated questionnaire used in occupational health care in 
Sweden [58]. The physical activity question included a definition of exercise, that is, to 
allocates time for exercise in order to maintain or improve fitness, health and wellness [58].  
3.4.7 Exercise and physical activity measurements 
In Studies II and III leisure-time physical activity was not registered during the 3-month 
group exercise intervention. The patients filled in an exercise diary at each training session 
and the coaches checked and signed the diary. The self-selected workouts were evaluated in 
groups of i) mixed aerobic fitness and strength training, ii) aerobic fitness training, and iii) 
strength training. The number of exercise sessions per week (t.p.w), the number of minutes of 
exercise per week (m.p.w) and the intensity during each session (6-20 Borg RPE Scale) were 
recorded. The number of dance therapy and Qigong sessions (replacing other types of 
exercise) – often chosen because of fear of movement or to improve balance and coordination 
– were registered and included in the sum total of exercise. An effort equivalent of at least 30 
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minutes of brisk walking corresponding to 11-13 Borg RPE Scale level was required for 
registration as an exercise session. 





A standardised and structured protocol was used by GPs to refer patients to the intervention 
programme. It included information on common diseases, joint pain or discomfort (14 
localisations), and medication, if any.  
3.4.9 Capacity to work 
The capacity to work, prevalence of sick leave, disability pension and/or job seekers’ 
allowance were also recorded in the protocol used by GPs when referring patients to the 
intervention programme. The length of time when a patient did not have capacity to work	  – 
that is, when no time was spent at work or on transportation in connection with work	  – was 
deemed to influence the total amount of patients’ physical activity and sitting-time. The 
variance in time to long-term follow-up in Study III could be influenced by this. 
3.5 MAXIMAL STEP-UP HEIGHT – A NOVEL ASSESSMENT OF LEG 
STRENGTH AND FUNCTION  
Stepping up onto something is a movement that is natural to most people. This was the basic 
idea behind developing a standardised test for measuring leg strength and function over time. 
A key criterion for the test at the stage of development was that it must be simple and realistic 
to use in ordinary clinical practice within primary health care for measuring step-up ability. 
The test also had to be easy to perform and repeat relatively frequently as leg strength and 
function are perishable. When patients were familiar with the test, it was performed within a 
few minutes. The clinical assessment of the patient in movement generated a great deal of 
important information.  
We have found no other studies in which a patient’s maximal step-up height has been tested at 
small intervals in a standardised way. In our study, the standardised intervals were 3 cm on a 
step-up box built by the author (Figure 4). In previous studies, subjects have been required to 
climb up to certain predetermined levels, or climb up and down with or without the help of 
handrails [59-62]. For instance, leg function was tested in a non-standardised way by having 
the patient mount an ordinary platform with five levels and step height correlated to muscle 
strength in older people [59, 61] and patients with knee and hip OA [62]. Elsewhere, 
assessment of middle-aged meniscectomised patients based on a footstool climbing test with 
few levels did not provide acceptable results when test-retest and floor/ceiling effects were 
taken into account [60]. Although there are several tests assessing leg function with both 
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multifactor and functional ability assessment tools [63-64], a systematic review concluded 
that no single tool can be recommended for implementation in all settings or for all 
subpopulations within each setting [65]. A consensus-derived set of performance-based tests 
of physical function for use in people diagnosed with hip or knee OA or following joint 
replacement have recently been presented [41] with comments [66] and a reply by the authors 
[67].  
Many tools for the assessment of fall-risk prevention among older adults have also been 
studied. We sought to evaluate an assessment tool suitable for all ages by being differentiating 
and difficult enough to perform also for young and middle-aged persons. The test for leg 
strength and leg function in this thesis was developed in order to be a standardised procedure 
suitable for daily clinical use. Standardisation, carried out in the author’s clinical practice, 
started with assessing patients’ ability to step up on one or two ordinary stairway steps. This 
only discriminated for 18 and 36 cm. Therefore a maximal step-up test (MST) with 3-cm 
intervals between step heights was developed for assessment of maximal step-up height 
(MSH). The rationale for choosing 3-cm intervals was 
1. to have enough levels for discrimination between subjects/patients and test occasions,  
2. to have sufficiently few levels not to exhaust subjects/patients and  
3. to be able to come as close as possible to the highest theoretical individual MSH due to 
standardisation while taking 1. and 2. into consideration.  
In our study, the highest step-up height reached with the standardised MST at a specific test 
occasion is denoted as ‘maximal step-up height’ (MSH). The individual goal suggested was to 
manage MSH with 90 degrees in hip and knee in the start position. Experience from the 
standardisation process suggests that it is possible to reach that level even at a high age 
provided strength fitness is high.  
The standardised maximal step-up test (MST) method includes instructions for the tester on 
how to instruct and encourage the patient during the MST. The new standardised MST [1] 
determines the greatest height to which a subject/patient can step at that moment (MSH). We 
study if it can be an easily available and robust assessment of leg strength and leg function in 
clinical practice, for diagnoses, treatment and follow-up of individuals at risk and for patients 
with chronic diseases and limitations in capacity to work. 
	   	   	  
	  
24 
3.6 MAXIMAL STEP-UP TEST – STANDARDISED INSTRUCTIONS 
The maximal step-up test (MST) assesses maximal step-up height (MSH) at a particular 
moment as seen in the images below (Figure 4). What follows are detailed instructions to be 
used by the tester and subject. 
I. Begin your demonstration of the MST with the height set at a relatively low level; that is, 
to correspond to the height of a step of an ordinary flight of stairs. The step-up test is carried 
out in ordinary cloths and in bare feet or socks. To avoid any undesirable side effects an 
incremental increase of height is recommended. 
II. During the step-up demonstration, carefully explain the rules for the approved MST: 
i. the foot of the step-up leg should be put in a place where good balance can be 
established  
ii. the arms should hang vertically at the sides  
iii. stand in an upright position  
iv. move slowly while performing the step-up  
v. the pelvis should remain in a central position during the step-up 
vi. avoid kicking off from the floor with the foot still on the floor  
vii. tilting backward or forward, or bending forward with the face passing the vertical line 
from patella, is not allowed. 
III. After the demonstration ask the subject if there are any current or previous problems 
with leg function, joint pain or muscle weakness. Select a level at a low step-up height for 
training purposes, and start with what the subject considers the strongest or dominant leg, to 
obtain familiarity with the test procedure. Then choose an MST start level at which the 
subject feels certain of being able to perform the test procedure in full compliance with the 
instructions. Then ask the subject to start the MSH assessment with the leg suspected to be the 
weakest. If an approved MST is not carried out, try a lower level as the starting level.  
IV. Testers’ instructions to subjects during the MST (see legend to Figure 4) 
V. The tester supervises and approves the MST on one or both legs and the subject is then 
told to try a higher level. Three attempts at the highest level for each leg are allowed. The 
subjects are given verbal encouragement to perform at their best. The highest approved level 
is the maximal step-up height for each leg. 
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Figure 4. The standardised maximal step-up test (MST) – instructions to subject 
 
First image. At starting position put the floor foot 5-10 cm in front of the step-up box, and 
put the step-up foot onto the board. Finish starting position by getting up as high as possible 
on the toes of the floor foot. Stand still and find your balance.  
Second image. Look straight ahead and straighten your back while moving your body weight 
over to the step-up leg on the board of the step-up box. Stand still and again find your 
balance.  
Third image. Start the step-up by pressing the step-up foot into the board. During a slight 
forward bend, and without kicking with the floor foot, slowly step up onto the board while 
extending your knee and hip.  
Fourth step. Slowly put the floor foot onto the board of the step-up box and the MST is 
completed. 





The statistical methods used in the three studies are summarised and presented in Table 1. 
Analyses were done both as intention to treat (ITT) and as per protocol (PP) and there were 
no significant differences. Results from the ITT analyses are presented in Studies II and III. 	  




I II III The primary outcome variable for the statistical analyses of 
this thesis was the maximal step-up height (MSH), where 
the mean and standard deviation (SD) of right and left leg 
was used for all MSH analyses. 
     
Descriptive 
statistics  
   All data were analysed with descriptive statistics, at baseline 
and follow-ups. 
Mean (SD)  ▪ ▪ ▪ Mean and standard deviation, for all continuous variables at 
baseline and follow-ups 
Frequencies 
(%) 




▪ ▪ ▪ Relative frequency for all categorical variables  
SF-36  ▪ ▪ ▪ Scoring according to the first Swedish version was used. All 
raw scores were transposed onto scores on a weighted 0-100 
scale, higher scores representing better health status. The 
subscale PF was extracted for further item analyses of the 
limitation level in the PF items ranging from 1-3 
(1=severely limited, 2=somewhat limited, 3=no limitation), 
and the summary of item responses:  
I. 3a, 3b, 3d, 3f and 3g ; II and III: 3b, 3d, 3f and 3g. 
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Analytical 
statistics 
   The three studies were exploratory, had a wide focus with 
several objectives with unknown baseline values, effects, 
and distribution of the outcomes, therefore no power 




 ▪ ▪ Mean difference for all categorical and continuous variables 
after intervention up to both follow-ups were computed. 
ANOVA 
 
▪  ▪ Estimating the within-subject standard deviation for further 
calculation of MSH – the test-retest repeatability was 
analysed, 95% of differences between paired observations 
was expected, to be less than this definition of a 
repeatability adopted: 
I. – between paired observations, i.e. test leaders and 
subjects repeated assessments, respectively in a working 
population both women and men. 
III. – between paired observations, i.e. test leaders, in a 
female patient population with common diseases and 




▪ ▪ ▪ I. To determine whether MSH at occasion 1, the mean MSH 
between the first and second assessment was: 
i. Tested for discrimination of a cut-off score (cm) for any 
limitation (numerically <100) or no limitation (=100) in SF-
36, PF score (item 3a-3j)  
ii. tested for discrimination of a cut-off score (cm) for 
presence of any limitation dichotomized (1 and 2) versus no 
limitation (3) in SF-36, PF item response 3a, 3b, 3d, 3f and 
3g.  
II. To estimate the odds ratio (OR) and the corresponding 
95% confidence interval (CI) for presence of severe 
limitation (item response 1) versus little or no limitation 
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(item response 2 and 3) in SF-36, PF items summary 3b, 3d, 
3f and 3g. MSH was included as the independent factor in 
the model, a cut-off level (cm) was estimated for severe 
limitation versus other. 
III. Logistic regression analysis was performed to explore 
subjects with maintained MSH as outcome (maintained or 
increased MSH versus decreased MSH). Mixed aerobic 
fitness and strength training sessions were dichotomized 
into high (>21 sessions during the 3-month training period) 
or low (≤21 sessions). Age (years), time to follow-up 
(months) and MSH (cm) at baseline were included as 
covariates, as these were found to be significant in 
univariate regression analyses. 
Odds Ratio 
(OR) 
▪ ▪ ▪ I and II. A cut-off level (cm) was estimated where the odds 
ratio (OR) for any limitation was set to 1.0, discriminating 
between those who have a limitation of the SF-36 PF items 
specified in the analyses and those who did not have that 
limit. 
III. Logistic regression analysis was performed and results 
are presented as odds ratio (OR) with 95% confidence 
interval (95% CI). Model specification was tested by 





▪ ▪  The cut-off level observed was used to compare predicted 
values against observed values. The measures of sensitivity, 
specificity and likelihood ratio (LR) were calculated to 
address the potential for MSH to discriminate subjects with: 
I. Any limitations (item response 1+2) in SF-36, PF in items 
summary of 3a, 3b, 3d, 3f and 3g. 
II. Severe limitation (item response 1) in SF-36, PF in items 
summary of 3b, 3d, 3f and 3g. 
Pearson 
Correlation 
▪ ▪ ▪ I. Validity of MSH was investigated by analysing the 
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Coefficient relation between: 
i. MSH at occasion 3 and mean isokinetic knee extension 
peak torque (IKEPT) of the right and left leg, ii. MSH at 
occasion 1 and SF-36 subscales PF, BP and GH scores (0-
100) and PF the items response summary of 3a, 3b, 3d, 3f 
and 3g.  
II and III. Mean difference for all categorical and 
continuous variables after intervention at 3-months and 14-
30 months follow-up, respectively, was computed and 
correlations, explorative univariate relation between all 
variables and MSH, were calculated. 
T-test  ▪ ▪ II and III. Main variables and their changes from baseline 
to 14-30-month follow-up and changes to after the 3-month 
intervention programme were analysed using the students T-
test. All tests were two-sided and P<0.05 was regarded as 
statistically significant. No adjustments for multiplicity were 
done as this is an exploratory study. Overall, we can expect 
1/20 statistical significant results to be caused by random for 




  ▪ III. To describe differences (rank order) in MSH 
correlations to subjects main variables between the two 
subgroups with the highest MSH maintenance (increased or 
maintained) and the subgroup with the lowest MSH 
maintenance (decreased), the Mann-Whitney U-test, 2*1-
sided exact p-test was used. The same when analysing 






▪ ▪  I. MSH at occasion 3 was used to assess the relation to 
demographic factors such as sex, age, weight, body height, 
BMI and mean energy expenditure using multiple linear 
regression.The multivariate analyses were performed in two 
models. 
II. The multivariate correlations between MSH and age, 
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aerobic fitness, self-estimated physical functions and 
physical activity, anthropometric variables, diseases and 
complaints as well as characteristics of the physical activity 
intervention programme were analysed. The multivariate 
analyses were performed in three models, for correlation to 
MSH at baseline, at 3-month follow-up and to change in 




▪ ▪ ▪ I, II and III. Correlations were calculated using the Pearson 
Correlation Coefficient to explore univariate relation 
between all variables and MSH. For exploratory use as 
separate univariate tests of significance may not be 










4.1 STUDY I 
4.1.1 Characteristics of the study population 
The characteristics of the subjects and scores on the SF-36 subscales are presented in table 1 
in Study I. The mean BMI indicates that both women and men were overweight. Energy 
expenditure data indicate moderate physical activity among men and less among women. 
Subjects from both sexes ranged from inactive to moderately active, and were representative 
of patients in primary health care most commonly referred to physical activity on prescription 
today [68-70]. Assessment of SF-36 showed that our subjects had marginally better PF and 
BP than, and about the same GH as, the general Swedish population [53]. In our study 58.3% 
(34-64 years) had at least one limitation in PF, compared with 60.6% (35-64 years) in the 
general Swedish population [53]. Our subjects thus appear representative for the middle-aged 
general population in Sweden. Nearly all limitations reported by our subjects were found in 
items 3a, b, d, f and g. Older subjects and women reported a greater number of limitations. 
The MSH range was 12-45 cm for women and 18-45 cm for men. The mean (SD) maximal 
step-up height (cm) for each leg for all assessments at occasions 1, 2 and 3 are presented in 
Table 2. The differences between legs and assessments were minor.  
Table 2. Maximal step-up height mean values right and left leg 
 
4.1.2 Repeatability 
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The intra-tester test-retest (one week between occasions) showed MSH repeatability of 6.9 
and 5.9 cm for right and left leg, respectively. When four weeks passed between the first and 
third occasion the corresponding figures were 5.0 and 4.9 cm. The inter-tester (minimum 30 
minutes) repeatability was 9.6 and 8.5 cm (occ 1), and 6.6 and 5.6 cm (occ 2), for the right 
and the left leg respectively.  
4.1.3 Correlations 
Mean MSH – that is, the mean of right and left leg – at test occasion 3 (T3) was correlated to 
age and gender (Figure 5) and to BMI and gender (Figure 6). MSH was correlated to 
isokinetic knee extension peak torque (IKEPT) (r=0.68, P<0.001) (Figure 7), to SF-36, PF 
score (r=0.29, P=0.03) and to limitations in the selected items in PF (3a, b, d, f, g) (r=-0.30, 
P=0.02). MSH was not correlated to the BP (r=0.08, P=0.53) or GH (r=0.02, P=0.88) scores 
of the SF-36.  
Figure 5. Maximal step-up height in relation to age and gender 
 




Figure 6. Maximal step-up height in relation to BMI and gender  
 
Figure 7. Maximal step-up height and quadriceps strength 
 
4.1.4 Regression analysis 
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The correlation of MSH to subject characteristics and self-reported physical activity is 
presented in Table 3. Both models revealed significant inverse correlations. The first model 
revealed significantly lower MSH among women, and lower MSH with increasing age and 
BMI. The second model showed significantly lower MSH among women, and with increasing 
age and higher weight. Body height and self-reported physical activity did not significantly 
correlate to MSH. Results from the logistic regression modelling showed that MSH at the first 
test occasion could discriminate limitations in physical functioning, OR=1.13, P=0.037, and a 
corresponding cut-off level at 34 cm. The model had a sensitivity of 71% and a specificity of 
58%. Subgroup calculations showed a cut-off level of 32 cm for women and 35 cm for men, 
which discriminated those reporting any limitation in SF-36, PF. There were 7 out of 30 
women and 14 out of 30 men having MSH >32 cm and >35 cm, respectively, on both legs. 
Leg problems and injuries (>6 months before study) reported by the subjects could explain 
lower MSH and IKEPT values as well as low values in PF scores. The subjects did not report 
any adverse effects of the study and there were no drop-outs. Performing the MST took 5-15 
minutes and IKEPT took 25-30 minutes. 
Table 3. Linear regression: mean maximal step-up height at test occasion T3, n=60 
 
4.2 STUDY II 
4.2.1 Response rate 
178 patients (83% response rate) were included. The reasons not to attend the intervention 
project were diverse (Figure 3). The reasons for not coming to 3-month follow-up (22 
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patients, 12%) were: premature ending of supervised training without explanation, starting a 
new job or education, psychosocial reasons or moving away. 
4.2.2 Patients’ characteristics  
At registration, nearly three in four of the patients (72%) reported exercising either never, 
occasionally or at most one to two times per week. One quarter (24%) reported that they 
participated in leisure-time activity/structured exercise lasting at least 30 minutes either three 
to five times per week or more than five times per week. Of the 178 female patients included, 
97% had musculoskeletal complaints. Three quarters (75%) of those with musculoskeletal 
complaints had pain or dysfunction in two to five out of 14 possible localisations reported in 
the standardised referral document by the patient’s GP. Altogether, 49% (88 out of 178 
patients) also had at least one of the psychosocial conditions diagnosed as common practice in 
primary care: depression, anxiety, stress-related problems, sleep disturbance, burn-out 
syndrome or fibromyalgia. One fourth (26%) had been diagnosed by their GP with 
cardiovascular disease, 12% with type 2 diabetes and 12% with asthma/COPD. A majority 
(66%) was on part-time or full-time temporary disability pension or on sick leave as reported 
by GPs. 
4.2.3 Descriptive statistics and intervention effects 
Descriptive statistics for age, anthropometric variables, cardio-respiratory fitness, self-
reported physical and mental function, at baseline and after 3-month intervention, are 
presented in Table 4. Body weight and aerobic fitness improved after the intervention period. 
Physical and mental functions also improved. Four different dimensions of physical 
limitations, as measured by SF-36, improved: these were the items describing doing moderate 
activities (3b), climbing several flights of stairs (3d), bending, kneeling or stooping (3f) and 
walking more than 2 km (3g). 
Table 4. Mean (SD) for age, anthropometric variables, cardio-respiratory fitness, self-
reported physical and mental function, at baseline and after 3-month intervention with group 
training 
Age, anthropometric variables 
and aerobic fitness 
n Baseline 
Mean (SD) 
Change baseline to 3-month 
follow-up, Mean (SD) 
 age (years) 156 49.9 (12.0) 0.4 (0.5) p<0.001 
 height (cm) 156 163.9 (6.6) NA  
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 weight (kg) 155 79.5 (18.0) -0.8 (3.2) p=0.002 
 BMI 155 29.6 (6.5) -0.3 (1.1) p=0.001 
 waist (cm) 151 95.2 (14.8) 0.3 (3.7) p=0.307 
 VO2 max (mL·kg-1·min-1) 121 27.8 (8.0) 5.0 (5.4) p<0.001 
¹SF-36 score (0-100) n=156 Baseline 
Mean (SD) 
Change baseline to 3-month 
follow-up, Mean (SD) 
Physical     
 PF-Physical function  64.7 (20.4) 6.4 (15.7) p<0.001 
 RP-Role limitation physical   34.3 (38.9) 9.0 (37.8) p=0.004 
 BP-Bodily pain  39.5 (21.0) 8.7 (18.4) p<0.001 
 GH-General health  44.9 (18.4) 8.0 (16.1) p<0.001 
Mental     
 VT-Vitality   34.9 (21.5) 13.3 (21.7) p<0.001 
 SF-Social function  64.9 (27.4) 7.8 (25.4) p<0.001 
 RE-Role limitation emotional  53.4 (45.2) 6.2 (43.3) p=0.076 
 MH-Mental health  62.7 (23.1) 6.4 (18.9) p<0.001 
NA=Not applicable 
¹SF-36, the Swedish version of a generic health-related quality of life survey, consists of 36 
items that cover eight domains of health status. All raw scores were transformed into scores in 
a range between 0 and 100, and higher scores represented a better health-status score.  
Mean maximal step-up height (MSH) in the total group increased by 1.6 cm from baseline to 
follow-up after 3-month intervention (Table 5). When the data was analysed for different 
subgroups we noted 7.8 cm higher mean MSH (mean right and left leg) in the youngest 
compared to the oldest age group and 5.7 higher mean MSH (mean right and left leg) in the 
group with VO2 max ≥40 ml compared to the subgroup with <25 ml.  
No adverse effects of the MSH assessments and no adverse effects from group training 
leading to interruption were reported. Performing the MST took between 5 and 15 minutes 
depending on the patient’s physical condition and whether it was the MST at baseline or at 
follow-up. 




Table 5. Mean (SD) of maximal step-up height (MSH) at baseline and changes from baseline 
to after 3-month intervention. Significant difference analysed, two-sided at p<0.05, is marked 
in bold.  
MSH at baseline and changes to  
3-month follow-up (n=140) 
Baseline 
Mean (SD) 
Change baseline to 3-month 
Mean (SD) 
 Left leg (cm) 27.1 (6.3) 1.4 (2.6) p=0.069 
 Right leg (cm) 26.9 (6.0) 1.7 (3.2) p=0.021 
 Mean of right and left leg (cm) 27.0 (5.9) 1.6 (2.5) p=0.033 
4.2.4 Pair wise correlation analysis 
Maximal step-up height – that is, maximal step-up height the mean of right and left leg (cm) – 
had significant negative correlations to age, weight, BMI and waist circumference. It 
correlated positively to SF-36 physical function score (the ten items 3a-j), VO2 max, height 
and musculoskeletal pain and disorder(s) from lumbar spine to foot. Some correlations at 
baseline between MSH and other main variables are presented in Figures 8-13. However, 
maximal step-up height was not correlated to physical activity >30 minutes per day with the 
intention of maintaining or improving aerobic fitness, health or wellbeing before the 
intervention. At 3-month follow-up MSH correlated significantly to the same variables, and 
also to training intensity, but not to total number of training sessions (101, 47 and 8 patients 
with ≥25, 13-24 and ≤12 sessions, respectively), and not to ‘doing moderate activities’ (PF 
item 3b) or to pain from lumbar spine to foot reported at baseline.  




Figure 8. Maximal step-up height correlated to age (baseline, n=178) 
 
Figure 9. Maximal step-up height correlated to BMI (baseline, n=178) 




Figure 10. Maximal step-up height correlated to waist circumference (baseline, n=178) 
 
Figure 11. Maximal step-up height correlated to SF-36 physical function (baseline, n=178) 




Figure 12. Maximal step-up height correlated to VO2 max (baseline, n=178) 
 
Figure 13. Maximal step-up height correlated to height (baseline, n=178) 




MSH changes from baseline to three months correlated with changes in weight, BMI, waist 
circumference, physical limitations and physical function, but not with changes in VO2 max 
(Table 6). Analyses were done both as intention to treat (ITT) and as per protocol (PP) and 
there were no significant differences. 
Table 6. Correlation in pairs of mean maximal step-up height ¹(MSH) changes and changes in 
other variables from baseline to 3-month follow-up after group training analysed with 
intention to treat (ITT). Significant correlation, two-sided at p<0.05, is marked in bold.  
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1) MSH i.e. the mean of right and left leg (cm) (n=140), 2) weight (kg) (n=155), 3) BMI i.e. 
body mass index (n=155), 4) waist circumference (cm) (n=151), 5) VO2 max i.e. maximal 
oxygen uptake (mL·kg-1·min-1) (n=104), 6) sum3bdfg, PF, SF-36, i.e. summary of item 3b, 
3d, 3f, 3g any limitations score (1=severe, 2=somewhat, 3=no limitation) (n=156), 7) PF i.e. 
physical function, SF-36 (score 0-100) (n=156). 
4.2.5 Regression analysis 
Multiple regression analyses showed that the change in maximal step-up height (MSH) from 
baseline to three months correlated negatively with change in waist circumference and 
positively with change in the sum of physical limitations in items 3b, 3d, 3f and 3g, where 
high scores indicate no limitation (Table 7). No correlation was found between change in 
MSH (mean of right and left leg) from baseline to 3-month follow-up and change in VO2 max 
or patients’ age. We noticed linearity between patients’ age and changes in mean VO2 max 
and changes in physical limitations at 3-month follow-up when added together to Model 3. 
Nearly all the patients (n=172 out of 178, 97%) were assessed with the maximal step-up test 
at baseline. Only 137 women (75%) could perform the VO2 max test on the bicycle, mostly 
because of medications that interfered with the test (n=27). Others who were not tested with 
the cycle ergometer had stress-related problems with a heart rate too high for an appropriate 
calculation of VO2 max from the sub maximal exercise test. 
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Using logistic regression, we estimated a maximum of MSH of 24 cm as a cut-off to 
discriminate those who self-reported severe limitation in at least one of the PF items 3b, 3d, 3f 
and 3g. Comparison of observed versus predicted values based on the cut-off level of 24 cm 
showed 64% agreement. The model had a sensitivity of 83% and a specificity of 39% 
explained by age and BMI. 
Table 7. Regression summary for dependent variable mean maximal step-up height ¹(MSH) 
assessments of 156 female patients at baseline and at follow-up after 3-month intervention 
with group training. The regression summary for dependent variable changes of mean MSH 
and changes of variables after 3-month intervention. Changes analysed as ITT. Significant 
difference, two-sided at p<0.05, is marked in bold. 
 Model 1 – baseline Model 2 – at 3 months Model 3 – changes to 3 months 
Variables  B 
(n=114) 
SE(B) p-value B 
(n=98) 
SE(B) p-value B 
(n=98) 
SE(B) p-value 
2age -0.15 0.04 <0.001 -0.11 0.04 0.008 0.03 0.02 0.220 
3waist -0.13 0.04 <0.001 -0.14 0.03 <0.001 -0.17 0.07 0.014 
4VO2 max 0.11 0.06 0.070 0.03 0.05 0.639 0.02 0.05 0.697 
5sum3bdfg 0.42 0.20 0.037 0.54 0.23 0.023 0.39 0.17 0.022 
6intensity    2.17 0.71 0.003    
Model 1 – R²=0.461; Model 2 – R²=0.565; and Model 3 – R²=0.138.  
1) MSH i.e. maximal step-up height the mean of right and left leg (cm), n=140, 2) age at 
baseline used in analysis in Model 3, age changes about three months for all, 3) waist 
circumference (cm), co linearity to BMI and weight, 4) VO2 max i.e. maximal oxygen uptake 
(mL·kg-1·min-1), 5) sum3bdfg i.e. any limitations in SF-36, physical function, items 3b, 3d, 
3f, 3g, 6) intensity i.e. group training intensity from level one to three, light-light, light, 
ordinary level according to the music pace, the patients’ lowest was registered.  
4.3 STUDY III 
All tables and figures for this section are included in Study III at the back of the thesis. 
4.3.1 Repeatability test at long-term follow-up 
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The inter-examiner (minimum 30 minutes) repeatability was 3.94, i.e. in 95 % of the mean 
MSH right and left leg assessments. A variation of up to 4 cm can be expected between 
testers. 
4.3.2 Characteristics of the study population at baseline 
Some characteristics of the study population are presented in tables 1a and 1b. The mean BMI 
and mean waist circumference at baseline described that a majority of the study population 
was overweight and abdominal obesity was common. Mean (SD) VO₂ max was rather low 
27.5 (7.3) mL·kg-1·min-1 and MSH was 27.2 (5.7) cm.  
Furthermore, 74% were co-habiting and 20% were smokers. 18% of participants reported 
having completed elementary school as their highest educational qualification, 46% upper 
secondary school and 37% degree level at university or college. The exercise habits before the 
age of twenty varied considerably: 2% reported being exempt from physical education (PE) 
class at school, 38% reported no training other than PE, 36% reported exercising through non-
competitive participation in a ball sport, 19% did participate in both exercise and competitions 
and 5% were serious participants in athletic competitions. 
4.3.3 Changes in exercise and physical activity, SF-36, capacity to work and sick 
leave  
As the long-term follow-up (the third assessment, T2) was conducted across three months, 
whereas participants had been referred to the study consecutively over a longer period of 
time, we obtained a time range between T0 and T2 of 14-30 months (mean 22 months).  
Significant increases in self-reported exercise/PA five levels onto mean 22-month follow-up 
were analysed, see table 1a. The main activity reported from patients’ diaries at T2 was brisk 
walking consisting of ≥30 minutes per day on an average of five days of the week. A 
substantial decline in group exercise was reported three months before T2 compared to T1, 
see additional file 1.  
Significant improvements in SF-36 scores were seen in all scales at both follow-ups as seen in 
table 1b. From SF-36 the items 3b, 3d, 3f and 3g were evaluated separately and increased 
ability were seen in three of four of these physical functions, the limitations for knee bending 
(3f) did not significantly change by the two follow-ups. Compared to baseline there were 
some improvements concerning great limitations for ‘bending knees’ at the 3-month follow-
up for 6 out of 19 patients, but this change did not persist at long-term follow-up, see table 1b.  
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The proportion of patients with capacity to work – including workers, job seekers and 
students – had increased from 33% to 58% by T2. The mean degree of sick leave – as a share 
of 1.0 (SD) – at T0 and T2 for the subgroup with highest maintenance of MSH (n=27) were 
0.45 (0.46) and 0.21 (0.41) (p=0.002) respectively. These degrees were compared to the non-
significant change in degree of sick leave from T0 to T2, 0.48 (0.46) and 0.28 (0.44) 
(p=0.121) respectively for the group with lowest MSH maintenance (n=22).  
4.3.4 Changes in MSH and metabolic risk factors after group exercise intervention    
MSH values from all three test occasions were plotted along a time axis and a large 
distribution of MSH values could be seen at baseline as seen in figure 1a. When we placed 
three measurements at three places along a time axis, the positive change in MSH during the 
3-month group exercise intervention programme was more clearly visualised, as was the – 
often parallel – decreases in MSH up until the long-term follow-up as shown in figure 1b.  
Significantly lower weight and BMI were seen at the 3-month follow-up, but there were no 
changes in these variables at the long-term follow-up as seen in table 1a. Waist circumference 
was not changed at 3 months but was significantly lower, -2.4 cm, compared to baseline at the 
long-term follow-up, tables 1a and 2. Significantly increased VO₂ max at both follow-ups and 
increased MSH at 3-month follow-up and decreased MSH at long-term follow-up were noted 
(table 2).  
We found no significant seasonal differences in mean MSH at T0 and T1 or MSH changes 
from T0 to T1 assessments between seasons.  
4.3.5 Other subgroup analyses of MSH and changes of MSH at follow-ups 
When the whole group was divided into tertiles by age at T0 there were differences in MSH, 
waist circumference and VO2 max between groups. The middle age group had measurements 
closer to the oldest group as seen in table 2. Furthermore, other subgroup analyses presented 
in additional file 2 show that obese patients with type 2 diabetes had a steeper MSH decline 
than obese patients without diabetes after the 3-month intervention programme. A steeper 
decline in MSH was also found for patients with only hip pain compared to those with 
combined hip/knee or only knee pain. Additional file 2 also presents supervised group 
exercise intensity, neck and shoulder pain and mental diseases. The subgroup explorative 
analysis of mean MSH and MSH changes between T0 and T1, and T0 and T2, respectively.  
4.3.6 MSH correlations and regression analysis 
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Univariate correlations between main variables and the changes from baseline to follow-up 
after 14-30 months are shown in table 3. The decline in MSH correlated to follow-up time and 
changes in weight, BMI and waist circumference. Reduction in waist circumference was 
significantly correlated with the total number of registered exercise sessions before long-term 
follow-up (table 3). 
Two models for multivariate regression analysis were performed: the first model is recorded 
in table 4a (R²=0.620) with MSH at 14-30 months as dependent variable; and the second 
model is recorded in table 4b (R²=0.426) with the change in MSH from baseline to long-term 
follow-up as dependent variable. The cardio-metabolic risk variables and the follow-up time 
are included in the models.  
As demonstrated in table 4a, MSH is affected by age and metabolic factors, but not by length 
of time to follow-up. This result contrasts with the change in MSH (table 4b) where the length 
of time to follow-up has the largest correlation to MSH maintenance, together with the change 
in BMI.  
Logistic regression was performed with maintained MSH as outcome, and in a univariate 
model the number of mixed aerobic and strength sessions was significant, OR 3.33 (95% CI 
1.25-8.89). In the final multivariate model (n=98) this factor was no longer significant, OR 
1.95 (95% CI 0.58-6.61). Covariates were the length of time between the first follow-up (T1) 
and long-term follow-up (T2) OR 0.78 (95% CI 0.68-0.90), MSH at baseline OR 0.88 (95% 
CI 0.78-1.00, p=0.043), and age at baseline OR 0.92 (95% CI 0.87-0.99). Goodness-of-fit by 
Pearson’s test was 0.20, and by Hosmer-Lemeshow’s test was 0.13.  




4.4 ANALYSIS OF FACTORS BEHIND DROP-OUTS 
Table 8. Age, anthropometric variables and aerobic fitness, at baseline and at 3-month 
follow-up 










age (years) 49.9 (12.0) 48.0 (10.8) 
height (cm) 163.9 (6.6) 163.4 (5.8) 
weight (kg) 79.5 (18.0) 79.4 (17.3) 
BMI 29.6 (6.5) 29.8 (6.6) 
waist (cm) 95.2 (14.8) 95.1 (14.2) 
VO2 max (mL·kg-1·min-1) 27.8 (8.0) 28.3 (8.3) 
Variables at 3-month follow-up, 
n=156 
Assessed MST both at 








age (years) 50.2 (12.1) 51.6 (9.7) 
height (cm) 163.9 (6.4) 163.3 (8.1) 
weight (kg) 78.9 (17.3) 76.8 (17.5) 
BMI 29.4 (6.4) 28.7 (6.0) 
waist (cm) 95.7 (14.5) 94.2 (14.6) 
VO2 max (mL·kg-1·min-1) 32.9 (9.7) 31.3 (13.0) 
 




5  DISCUSSION 
The main findings from this thesis were that the novel maximal step-up test assessing 
maximal step-up height is considered to be a useful and reliable test for leg muscle strength 
and leg function in clinical practice. Furthermore, it may also function as an indicator of 
metabolic health.  
The results of a 3-month group training intervention programme with 2-3 sessions per week 
of mixed aerobic fitness and strength training demonstrated increased maximal step-up height, 
improved fitness and self-reported health, and decreased risk in female patients with reduced 
capacity to work and an elevated cardio-metabolic risk. After an average of 22 months 
without regular group training, maximal step-up height was reduced again, while positive 
effects remained for waist circumference, VO2 max, physical function and physical activity. 
However, regular group exercise 2-3 times per week with mixed aerobic fitness and strength 
training was associated with maintenance of maximal step-up height, whereas brisk walking 
for at least 150 minutes per week was not sufficient to maintain maximal step-up height in a 
subgroup of women. 
In clinical care, it is essential to assess broad as well as specific aspects of physical function. 
Many earlier performance tests that measure a combination of muscle strength, leg function 
and aerobic capacity do not have a robust test standardisation procedure and do not 
discriminate between legs. Also, many earlier studies were performed on elderly populations 
older than 65 years of age, while in our study mean (range) age was 50 (22-83) years. 
The advantages of this new maximal step-up test include a focus on leg strength and function, 
the possibility to discriminate between the two legs and a standardised test procedure. The 
theoretical highest possible step-up height in accordance to standardisation (approximately 90 
degrees in the knee and hip joints in the step-up leg at the starting position) is individual, 
leading to reduced probability of ceiling effects irrespective of age.  
The maximal step-up test was found to be an easy-to-use and relevant assessment of leg 
strength and function for evaluating the effects of exercise – perishable goods, of course – and 
for planning individual patients’ exercise programmes during intervention. No adverse effects 
were reported from the MSH assessments. The maximal step-up test is regarded as a safe 
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physical performance test in our standardisation.  




5.1 STUDY I 
5.1.1 Main findings and reflections 
Study I shows that the maximal step-up test is a simple, robust, safe and relevant test for leg 
strength and leg function in both women and men in middle-age. Compared to IKEPT we 
rated MST as a fast test. The subjects’ limitations in physical function, their low to moderate 
energy expenditure and mean BMI>25 indicated that many of the subjects in our study would 
be suitable candidates for a physical activity prescription when they present themselves in 
primary health care. The measure of repeatability for this standardised MST indicates that 
95% of all differences between occasions should be less than 6 cm on group level. Larger 
differences are to be considered as ‘true’, reliable individual changes. Further, systematic 
changes on a group level – that is, differences between or within groups – may be detected at 
lower levels.  
The lower inter-tester difference between MSH at occasion 2 compared to occasion 1 could 
reflect a tester and/or subject learning effect. The threshold for maximum expected intra- and 
inter-tester differences in MSH in our study was 6 cm, which is less than the 10-cm interval 
used by other researchers when correlating step height to significant changes in leg strength 
and leg function, where subjects also had the possibility to kick off with the floor foot and to 
use handrails [61, 62, 71]. Future studies are needed to further investigate the clinical 
significance of the 6 cm repeatability. 
While not intending to predict knee-extension peak torque from MSH values, this study 
showed a significant correlation between MSH and IKEPT. This study indicates that MST is a 
valid test for knee extension function and less time-consuming. IKEPT values, used in our 
study as the gold standard, are highly reliable, and no learning effect has been observed [72]. 
Earlier results in two studies investigating the correlation between the maximum rising 
strength from sitting and isometric knee extension strength show correlations comparable to 
those in the present study [73, 74]. Furthermore, MST assesses leg strength and performance 
in functional positions and movements and does not require expensive equipment as does 
IKEPT measurements.  
We also found a significant correlation between MSH and SF-36, PF score and the sum of 
selected items 3a, 3b, 3d, 3f and 3g. Therefore, the standardised MST could be useful both to 
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identify consequences of sarcopenia [75] for early diagnosis and to support follow-up of 
treatment.  
Further studies are needed to investigate the effects of prescribed physical activity [69] on an 
individual’s MSH, most likely corresponding to changes in knee extension function and self-
reported physical function. In studies with older community dwelling populations objective 
measures of physical capability are predictors of all-cause mortality [76]. 
On speculation, we explored whether an MSH cut-off value could identify perceived 
limitation of physical function and found cut-off values of >32 cm (women) and >35 cm 
(men) on a group level. This might be of use for clinical assessment of the risk of falling or 
loss of functional independence in the future. Studies on larger groups of patients and 
comparisons with healthy subjects are needed before any further conclusions can be made.  
We present MSH correlations to sex, age and demographics in two models with multiple 
linear regressions in Table 3 indicating that the MST can be a useful tool for lifestyle 
interventions. In Model 1, where BMI was used in the model alongside weight and height as 
separately included, a certain correlation was found to weight whereas no correlations could 
be detected to height. The lack of correlation between MSH and body height in Model 2, also 
found by other researchers investigating step height [59], could be due to the relatively small 
size of the study. The MSH did not correlate to self-reported physical activity. Objective 
estimates of physical activity [77] might have yielded lower values and a different activity 
pattern, possibly with lower variability. If so, a correlation between MSH and physical 
activity might have been identified.   
5.2 STUDY II 
5.2.1 Main findings and reflections 
Maximal step-up height in Study II was correlated to self-reported physical function and 
limitations when performing common daily activities. Those patients who had an MSH of less 
than 24 cm had severe limitations when carrying out activities such as climbing several flights 
of stairs, kneeling or walking more than 2 km. It has been suggested that early assessment of 
and intervention to improve muscle strength are important for prevention of future functional 
limitations [78]. Thus MSH, when assessed at an early stage, could possibly be a useful 
measure to optimise a risk reduction prevention strategy. Assessing maximal step-up height 
could also be a useful complement to ordinary leg examination in clinical practice, not least as 
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a measurement of physical function and loss of function, and as a means for investigating if 
there are any differences between legs. 
Increases in maximal step-up height (MSH) after a 3-month group training intervention 
programme correlated to reductions in waist circumference and weight, and to improvements 
to self-reported physical function scores and physical limitation. This is in accordance with 
other studies on associations between muscle strength and cardiovascular risk factors for both 
women and men, and for adolescents [79, 80]. Significant correlation of MSH to intensity of 
exercise reflects the results reported in recent studies [81-83]. On the one hand, we already 
know that increased abdominal fat is associated with all common endemic chronic diseases 
like cardiovascular disease, type 2 diabetes, dementia [84-87], cancers [88] and symptomatic 
osteoarthritis [89]; and, on the other hand, we know that low muscle strength is an indication 
of risk factors for the same chronic diseases [19, 79, 84]. Therefore, we found it very 
interesting that leg muscle strength and leg function assessed with maximal step-up test was 
associated to cardiovascular risk factors such as waist circumference and VO2 max in a 
subgroup of female patient population.  
Sedentary behaviour, physical inactivity and low muscle strength are major causes of 
dysfunction, common diseases as well as premature deaths in modern societies. For as long as 
we lack valid and simple measurements in clinical practice, the promotion of physical activity 
and strength training will not get the attention it deserves in health care [90]. In this study on 
female primary health care patients, of which a majority (2/3) was on registered sick leave or 
had part-time or full temporary disability pension, we could show that the standardised 
maximal step-up test was a simple, robust, safe and relevant test. We found that the test was 
also useful for exercise instructors when coaching patients. Patients themselves also became 
aware of low leg muscle strength, limitations in step-up function and any differences between 
the two legs.  
The relatively low use of functional tests – for example, a 30-second ‘sit-to-stand test’ – when 
examining patients in clinical practice risks leaving GPs with an insufficient understanding of 
patients’ muscle strength and function, and may serve as an obstacle to prescribing physical 
activity as treatment. Reasons for this low use of functional tests may include 1) a lack of 
awareness of the importance or existence of such tests, 2) a lack of knowledge and training, 
leading to a general uneasiness about their use, 3) a perception that tests are not sufficiently 
clinically useful, 4) an assumption that tests may be too cumbersome to perform and 5) a lack 
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of reimbursement mechanisms for diagnostic and follow-up tests. It may also be the case that 
functional tests are indeed used by physiotherapists, but that the assessment outcomes are not 
communicated to GPs and nurses. In this study, MST was explored in female patients with 
musculoskeletal complaints, metabolic risk factors and other chronic diseases common in 
primary health care [91]. The patients demonstrated a high level of compliance with the 
exercise programme they had chosen, suggesting that a high level of adherence can be 
achieved in a self-selected exercise activity. The intervention programme with enjoyable 
group training and individual support from medically educated trainers could also have been 
of importance for compliance. 
5.2.2 MSH and correlates  
We found univariate correlation between maximal step-up height (MSH) and VO2 max at 
baseline, but not when tested multivariate with physical limitations (SF-36, PF the sum of 
reported limitations in items 3b, 3d, 3f and 3g) and age in the same model. Most likely, this 
was owing to co-linearity; that is, outcome measures assessing the same outcome variable. 
The MSH cut-off value 24 cm (below) had 64% sensitivity for identifying female patients 
(mean age 50 years) with at least one severe self-reported limitation in PF. For comparison, in 
Study I the upper cut-off values 32 cm (for women, mean age 53 years) and 35 cm (for men, 
mean age 55 years) had a sensitivity of 71% to identify those without any limitations recorded 
in SF-36. In light of the fact that physical activity is a complex set of behaviours, we need 
better diagnostic tools to identify relevant problems in individual patients. Therefore we find 
the information provided by the assessed maximal step-up height, measuring leg strength and 
function and differences between legs, useful when prescribing physical activity and exercise 
[69, 70], for lifestyle interventions [92], as well as for selecting patient characteristics in 
future research.  
5.2.3 Strengths and limitations of Study II  
One strength of our study was that it took place in ordinary clinical practice, was pragmatic, 
and we regard the clinical relevance as high. There is, in fact, a shortage of studies of leg 
strength and function performed on women. Our study population consisted of female patients 
recruited consecutively in routine primary health care. Another strength of the study was that 
the standardised maximal step-up test was validated on a patient population with overweight, 
obesity, reduced physical function or reduced aerobic fitness. These are known risk factors for 
low capacity to work and also for symptomatic osteoarthritis (that is, pain and reduced knee 
function) [93]. 
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Study II has some limitations. We decided to include only women in our study as two thirds 
of patients coming to primary health care are women, and also because only a small number 
of men were referred to the supervised physical activity programme. The data/results can 
therefore not be generalised for men, and neither for adolescents nor the oldest age groups. 
Another limitation is that the assessment of physical activity, at baseline and during the 
supervised training period, was not supported by step counting for a more accurate assessment 
of total daily physical activity. Furthermore, we had some missing data and one reason for 
this was that it was a clinical study. The individual maximal possible change in MSH after 
intervention is affected by the difference between a patient’s theoretical highest MSH [1] and 
her or his MSH level as assessed at baseline. Patients’ theoretical highest MSH was not 
measured and thus we could not take that variable into account when analysing our data. 
5.3 STUDY III 
All tables and figures for this section, written out in lower case, are included in Study III and 
referenced below. 
5.3.1 Main findings and reflections 
Our main findings were that a primary care-based 3-month group exercise intervention 
increased leg muscle strength and leg function assessed as maximal step-up height (MSH). 
Furthermore, we found that MSH was declining to below baseline level at 14-30 months 
follow-up. By that time, our female patients had stopped	  with their	  regular	  group training 2-3 
times per week, but reported brisk walking most days of the week as their main exercise. 
Furthermore, at the long-term follow-up, at a mean of 22 months, the patients still had 
remaining positive effects on waist circumference, VO2 max, self-reported health, physical 
function, exercise and physical activity. Moreover, at the first follow-up directly after the 3-
month period of group exercise as part of the intervention programme, patients had a 
significant decline in weight and BMI. Weight stability compared to baseline remained at the 
long-term follow-up. Clinically acceptable inter-rater variation is a minor concern compared 
to test-retest variation, which measures at 6 cm [17]. This means that to achieve high validity 
of MSH results within a study, it is more important that raters are robust in their testing 
methods than that we use several different raters.  
Group exercise included different workouts, mostly mixed aerobic fitness and strength 
training with a moderate to high intensity 13-15 on 6-20 Borg RPE scale, which the patients 
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were trained to use for intensity control. However, also sessions with merely strength, balance 
and coordination training were offered, see additional file 1.  
Analysing MSH subgroups according to level of maintenance of MSH at long-term follow-
up, we found that even the subgroup with the lowest maintenance of MSH maintained their 
MSH at the follow-up directly after the 3-month group-training period. Thereafter their MSH 
declined from different MSH baseline levels, figures 1a and 1b, and did so more steeply than 
for participants in the other subgroups. Most important for MSH decline – in a logistic 
regression multivariate analysis with maintenance of MSH as outcome – was the length of 
time before long-term follow-up, indicating a continuous decline of leg muscle strength and 
function detectable within a mean period of 22 months. Secondly, an increase in BMI and 
thereafter higher age (increased sarcopenia) and higher MSH levels at baseline were 
important for MSH decline.  
In the subgroup with the lowest maintenance of MSH, 44% of the female patients were 
assigned sick leave by the long-term follow-up compared to 27% of the patients with the 
highest maintenance of MSH. One reason for the decline in MSH may be extended absence 
from work where, without transportation to work and when not participating in any mixed 
aerobic fitness and strength training or just one session per week, patients were unable to 
maintain MSH. Also, many participants in the total group were overweight or obese at the 
start of intervention. Notable was that the obese patients in this subgroup of female patients 
had the highest MSH at baseline, but at long-term follow-up without regular group exercise, 
muscle strength to maintain the ability to move the body vertically was not enough and it was 
hardest for the obese patients to maintain MSH. If there had been significant statistical power 
when doing logistic regression analysis, mixed aerobic fitness and strength training would 
probably have had significant positive association with maintenance of MSH.  
Sickness and obesity, together with reduced capacity to work and insufficient daily physical 
activity, appear in our study to create this MSH decline earlier than muscle weakness due to 
age would have resulted in [40, 94], and with an increased cardio-metabolic risk. Higher BMI 
as determinant of decreased activity has previously been reported [95]. Furthermore, the role 
of increased sedentary behaviour (SB) – due to reduced working capacity and cessation of 
transportation to work – could be one reason for steeper MSH decline in our study, though SB 
was not assessed. Moreover, evidence presented in a recent meta-analysis shows lifestyle 
interventions as having the potential to reduce sedentary behaviour in adults [96]. As our 
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participants reported significant positive change in exercise and physical activity at long-term 
follow-up, the results from our study are in accordance with earlier studies. Our results are 
indicating that our female patients – who had a high metabolic risk at baseline – had moved 
from a low level of exercise/physical activity to a higher level with reduced cardio-metabolic 
risk.  
Thus those who could find regular group exercise with mixed aerobic fitness and strength 
training during holiday season – that is, the three summer months during which long-time 
follow-up assessments were carried out – increased their ability to maintain leg muscle 
strength and function assessed as MSH. Brisk walking most days of the week was not enough 
to maintain these individuals’ leg strength and function. Also, lower levels of support from 
primary health care professionals to encourage patients to prioritise regular group exercise – 
with mixed aerobic fitness and strength training 2-3 times per week with the subjective 
intensity of 13-15 on the 6-20 Borg scale – could be a reason for the steeper MSH decline 
beyond what would be expected due to age.  
5.3.2 MSH along a time axis visualises changes in muscle strength  
Patients with high baseline MSH appeared more frequently than others early on the time axis 
in the on-going intervention project, see figure 1a. One important reason for this was that 
patients with several diseases and consequently lower MSH were deemed not to manage the 
training intervention by their GP, for both physical and mental reasons. The opinions of GPs, 
however, changed over time after positive reports from patients. Analysing MSH change over 
time shows that a new functional status can appear quite rapidly, and this is related to 
decreased muscle strength. When changing to a more inactive lifestyle – for example, when 
being assigned sick leave, getting sickness benefit or being unemployed – with a rapid decline 
in muscle strength and function as a result, the metabolic and cardiovascular risks are 
markedly enhanced [97]. In occupational health, when preventing obesity and weight gain, 
early support measures have been recommended for obese employees in the form of a focus 
on enhanced physical functioning and treatment of obesity and its co-morbidities [98]. 
According to a recent European multicentre study, the greatest difference in mortality risk 
was observed between the two lowest activity groups for a population with abdominal and 
general adiposity, as in our female patient population [99].  
5.3.3 Mixed aerobic fitness and strength training with higher intensity important for 
MSH   
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In a meta-analysis, combined aerobic and resistance training – the most effective training 
modality to reduce anthropometric outcomes – have been recommended in the prevention and 
treatment of overweight and obesity whenever possible [100]. Mixed aerobic fitness and 
strength training 2-3 times per week in our study (see additional file 1) significantly improved 
MSH and VO2 max at both follow-ups and also reduced waist circumference at long-term 
follow-up. Brisk walking – as reported in our female patient population as the main exercise 
at long-term follow-up with the mean of 22 months – was at the level of the recommended 
150 minutes per week with moderate activity [6], but this was not enough for maintenance of 
their MSH. In a systematic review, interventions increased regular walking among targeted 
participants by 30-60 minutes per week on average, at least in the short term. Important for a 
successful increase was when intervention was tailored to participants’ needs and targeted at 
those with low physical activity [101]. The Karlskoga MABRA project intervention was 
designed on such principles. Furthermore, a recent study shows that walking groups are 
effective and safe with good adherence and wide-ranging health benefits. It was concluded 
that walking could be a promising intervention as an adjunct to other health care or as a 
proactive health-promoting activity [102]. Our patients’ experiences from the MABRA 
project intervention were probably important for long-term effects on achieving and 
maintaining the 150 minutes of PA deemed sufficient for good health in this subgroup of 
female patients. They were offered an individually tailored programme of exercise and regular 
medical support during intervention, as well as motivational interviews and physical activity 
on prescription at the end of the period of supervised group exercise.  
5.3.4 Health-economics and importance of tailoring exercise to participants’ needs 
A thesis from 2014 that assessed health-economic consequences of physical activity on 
prescription (PAP; FaR®), and that also identified the target groups benefiting most from this 
type of treatment of inactivity, showed that the resulting increased physical activity from PAP 
reduced costs to society by 22% due to reduced costs for health care and loss of production. It 
also demonstrated that if we target patients appropriately with the right dosage of physical 
activity, PAP for inactivity will be cost effective. Moreover, the analyses revealed the 
importance of increasing access to forms of physical activity and exercise to make it easier 
and cheaper for inactive individuals to be physically active, noting that weak socioeconomic 
groups value the health benefits of exercise lower than stronger socioeconomic groups. Two 
thirds of patients within the study did not complete the intervention programme of physical 
activity that had been set. They were deemed to need a higher level of help and support to 
	   	   	  
	  
58 
achieve the goals set, such as directed efforts by health care professionals [103]. The 
treatment of patients with physical activity studied in the MABRA project shows similar 
results for comparable groups. The results also show that the amount of time spent on exercise 
was associated with enjoyment of exercise [104, 105]. In the studies referred to in this section, 
a successful increase in physical activity has been shown when the exercise intervention has 
been tailored to participants’ needs and targeted at individuals with low physical activity. The 
group exercise intervention in the MABRA project was designed with the same intentions, 
showed sustainable clinical benefits and reported improvements of exercise and physical 
activity. Therefore this intervention could be recommended to women with common diseases 
and with low capacity to work as well as to patients with cardio-metabolic risks.  
5.3.5 Women in their 50s and cardio-metabolic risk 
When divided in tertiles by age, unexpectedly the women in their 50s (tables 2 and 3c) had 
lower aerobic fitness levels than the oldest age group. Also, their MSH level and waist 
circumference were in between the levels within the other groups, but closer to the lower level 
of the oldest age group than to that of the youngest group. It is known that cardiorespiratory 
fitness in general declines at a nonlinear rate which accelerates after 45 years of age [106], 
and possibly the situation is the	  same for MSH. Furthermore, it has been shown that elderly 
women with metabolic syndrome have lower functional capacity, muscle strength, lower limb 
power and flexibility when compared to women without metabolic syndrome [16]. With high 
waist circumference, low aerobic fitness and relatively low leg muscle strength within our 
female patients, metabolic syndrome is a probable diagnosis.  
5.3.6 Changes in MSH and metabolic risk  
The subgroup with the highest maintenance of MSH at long-term follow-up had a lower mean 
MSH (cm) (SD) at baseline, 26.7 (4.1) compared to 29.6 (6.0) in the group with the lowest 
maintenance of MSH. At baseline, the group with the highest maintenance compared to that 
with the lowest included some patients on sickness benefits or with disability pensions, which 
may be a possible cause of lower MSH. No significant difference was seen in mean levels of 
sick leave between groups at baseline. The opposite was the case for the group with the 
lowest maintenance at long-term follow-up when one fourth of the patients received either 
sickness benefits or disability pension, and nearly half (44%, n=22), compared to one third 
(27%, n=27) of patients in the group with the highest maintenance, were being assigned sick 
leave. When a person with overweight changes lifestyle in a short time – for example, going 
on sick leave and becoming less physically active without simultaneous weight loss – the 
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decline in leg muscle strength gives reduced ability to move the body vertically as assessed by 
the MST. Accordingly, the MSH decline we found in our study at long-term follow-up can be 
an early finding indicating effects of sick leave and lower leg muscle strength on the potential 
for increased cardio-metabolic and functional risks. Also, with rapid reduction in muscle 
strength and function and no change in energy intake, an increased weight may start a 
negative spiral towards an even higher BMI, leading to further decline in MSH. A majority of 
our patients were overweight.  
Another notable lifestyle change was that eleven out of twenty smokers had stopped smoking 
at long-term follow-up. The only tobacco cessation intervention strategy that was used in the 
project was instructions that no smoking must take place within two hours of tests or of group 
exercise. The medical and physiological reasons for this were explained and some general 
information about the adverse effects of smoking on fitness and general health were given. 
5.3.7 MSH, obesity and unhealthy obesity 
Our data presented in additional file 2 show that patients with obesity (BMI≥30) had a higher 
MSH at baseline than the group with overweight and normal BMI, in our subgroup of female 
patients, and that the body height did not differ. Furthermore, the obese patients showed less 
improvement of MSH during intervention and a steeper decline at long-term follow-up. More 
information about baseline MSH and the MSH changes in different subgroups are presented 
in additional file 2. A steep decline in MSH was seen for patients with T2D indicating loss of 
muscle strength and function and comparative reduction in metabolic capacity. In attempting 
to find an assessment method for detecting unhealthy obesity – that is, obesity with low leg 
muscle strength and metabolic function – the MST assessment of MSH could be considered 
useful when planning for future research.  
5.3.8 Changes in SF-36 scores and SF-36 physical function items  
In addition to patients’ increased metabolic and cardiovascular risks, mentioned above, lower 
self-reported quality of life in itself gives an increased risk of ill health. Comparing our 
patients’ mean SF-36 scores (broad standard deviations) in table 1b with normative Swedish 
female population scores (narrow confidence interval) for women in the age groups in 
question (45-54 years) [53] the differences in scores are PF 19, RP 49, BP 31, GH 30, VT 32, 
SF 22, RE 33 and MH 16. Significantly improved values compared to baseline were in our 
study measured at both follow-ups, see table 1b, and we suggest that an intervention of this 
kind should be further investigated in a larger context. 
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A recent study investigated whether physical activity and sedentary behaviours interact to 
influence feelings of energy and fatigue in women in their 40s. When insufficiently active, 
being less sedentary was associated with lower levels of fatigue comparable with women 
meeting the recommendations [107]. To join the regular group exercise in MABRA hugely 
influenced our patients’ feelings of energy and reduced fatigue. Patients showed strong 
positive improvements in self-reported health. The extremely positive feedback reported 
during and after the intervention, showing the great enjoyment gained by being physically 
active and by being so in a group [104], appear plausible reasons for the wide-spread 
tendency in patients to continue with daily walks to long-term follow-up.  
We analysed in more detail some questions in SF-36, PF, which measure the ability of 
completing activities at moderate strain level where leg strength might have importance for 
the estimated function, see table 1b. The ability to walk more than 2 km at a time without 
strain was the easiest task to achieve and keep until the long-term follow-up, but also those 
who improved their ability to escalate several flights of stairs without large or small difficulty 
could maintain this ability long-term. One third of the patients with reported large problems, 
mostly with knee bending, reported decreased limitations at the follow-up shortly after the 3-
month period of group training. At long-term follow-up the positive effect on knee function 
had returned to baseline, indicating the need for regular mixed aerobic fitness and strength 
training to sustain MSH. We conclude that the SF-36 items 3b, 3d, 3f and 3g are useful in 
clinical practice, primarily for screening leg muscle strength and leg function, to enhance 
individually prescribed exercise and to support patients in setting realistic goals.  
5.3.9 Strengths and limitations of Study III 
The study population was representative of female patients in Swedish primary health care. 
The intervention programme was received well by patients, despite substantial burdens of 
disease. There were no accidents requiring medical attention during or after the training 
sessions. All training sessions, except Nordic Walking, included music and in a recent study 
this was recommended to promote physical activity among sedentary individuals [108].  
The baseline and 3-month follow-up tests were distributed across three out of four seasons 
because of the way in which patients were added to the programme, and no seasonal influence 
was discovered.  
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One limitation is that we have not measured the sedentary behaviour or the physical activity 
more objectively, including intensity with an accelerometer or posture with an inclinometer. If 
so, we could have addressed some of the remaining questions about what is important for 
maintaining MSH. Another limitation is that when long-term results from subgroups are 
presented, each subgroup is comparatively small. Because this study is the first to describe the 
long-term results of MSH change after the intervention is completed, we believe it is useful to 
present the results to help plan future intervention studies, see additional file 2. Another 
limitation is that the study did not investigate the findings in a population of men. 
5.4 MAXIMAL STEP-UP TEST – ADVANTAGES AND POSSIBILITIES 
A recently published study showed that handgrip strength may not be an appropriate surrogate 
for lower body strength, power or balance, and is proposed only to be used describing upper-
body strength or functionality [109]. MST is a weight-bearing test that in an integrated and 
functional way assesses leg muscle strength, power, mobility, balance and coordination and is 
also indirectly a test of metabolic and cardiovascular risks as it is measuring the function of 
the body’s largest tissue with secretory capacity – the skeletal muscle.  
We suggest that MST can be used for future research to study the natural course of sarcopenia 
and osteoarthritis, the influence of exercise interventions on the risk of falls, as well as the 
morbidity and mortality in cardio-metabolic diseases, COPD and several other chronic 
diseases [110, 111]. Exercise has been recommended as a first-line treatment of degenerative 
joint disease of the knee and new research recommends that exercise should more closely 
target the sensorimotor deficiencies and functional instability associated with the degenerative 
joint disease of the knee than is the case in traditionally used training methods [50]. The 30-s 
chair-stand test, the 40-m fast-paced walk test and a stair-climb test were recently 
recommended as the minimal core set of performance-based tests for hip or knee 
osteoarthritis to be used in clinical practice [41, 112]. Also, the MST has been proposed as a 
recommended performance-based test to assess leg strength and function as well as 
differences between legs in people diagnosed with knee osteoarthritis [113]. 
The measurement of MSH has many advantages, already presented [1]: it is easy and safe to 
perform and immediately delivers a measurement value. Furthermore, it is inexpensive, and 
after brief instruction MST can be performed by health care staff with the help of step-up 
boards with different heights. Potentially, MST could, in everyday clinical practice on 
consecutive patients, allow the clinician and nurse to detect low muscle strength and 
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abnormalities in the locomotor system not observed with the patient in a resting position. A 
review has recently provided evidence that suggests aerobic exercise assessment to be a vital 
sign status in future clinical practice [114]. After the same considerations about the health 
effects and usefulness of assessment of leg strength, we suggest that assessment of MSH may 
serve as a vital sign status for assessment of muscle strength and function which could be 
used as a ‘health check’, both in clinical practice and when used as a self-test. Muscle 
strength, power and joint mobility are perishable, which is why repeated testing is needed, 
especially in patients with symptomatic degenerative joint disease of the knee and hip. 




6 FUTURE PERSPECTIVES 
6.1 eMSH – ESTIMATED MAXIMAL STEP-UP HEIGHT   
When assessing leg muscle strength and function with MST, it is useful to compare the 
person’s actual MSH level with her or his theoretical highest possible MSH when physically 
fit, according to standardisation. This enables us to give the person a ‘visualised individual 
goal’ for each leg as a target, the so-called estimated MSH (eMSH), to reach and maintain 
throughout life, from puberty onwards. During growth in adolescence, the eMSH will 
increase in parallel with body height. 
MST is likely to be a robust and easy-to-use test for assessing strength development, 
flexibility, joint mobility, side differences, balance and coordination in puberty, to be used in 
parallel with traditional measurements of increases in height and body weight. During growth 
in adolescence it is not unusual that sport injuries appear and an imbalance in flexibility and 
strength development can be found at examination. Future research will appraise what 
benefits MST may have for growing adolescents. Can repeated assessments of MSH during 
adolescence be beneficial for discovering imbalances in muscle strength and flexibility, to 
then be improved and trained during exercise in school (PE), not least to prevent excessive 
weight gain without enough parallel increase in muscle strength with increased health risks as 
a consequence? 
A few subjects of either sex in Study I managed to step up to a high level (39-45 cm). Their 
quadriceps strength assessed by IKEPT was high, they had good joint mobility, coordination 
and balance, and they reported no or tolerable pain. At this high level the femur was parallel 
to the floor, and the hip and knee angles were about 90 degrees at the starting position for the 
step-up leg, with the floor foot flat on the floor. This has been the routine for assessment of 
eMSH so far. 
To further increase the level of difficulty, beyond the scope of good and very good fitness 
(possibly primarily applicable to certain age groups), an advanced estimated MSH may be 
standardised. For this, the advanced estimated MSH (aeMSH) would be measured with the 
person being assessed standing with an angle of 90 degrees at hip and knee when the floor 
foot is in the tip-toe position, compared with keeping the floor foot flat on the floor at the 
point of assessment as for eMSH. To reach one’s advanced estimated MSH according to our 
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step-up standardisation, the person would need to be extremely fit with regards to leg muscle 
strength, maximum mobility, balance and coordination in relation to age, sex, body weight 
and, to a lesser extent, height. 
In summary, the highest MSH level in theory has been named the estimated maximal step-up 
height and will be abbreviated as eMSH. The most advanced estimated MSH, only applicable 
to extremely fit persons, will be abbreviated as aeMSH. 
aeMSH standardisation has been made in clinical practice in a pilot study (not published) on 
male middle-aged patients with type 2 diabetes (T2D) and on men from a recreational joggin 
group (11/13), already familiar with MST from taking part in Study I. Preliminary data 
showed additional clinically important information when calculating the change in difference 
between aeMSH and assessed MSH before and after a short daily training programme. The 
training programme consisted of repeated MST on each leg and slow controlled knee-bending 
exercises, using both legs, performed regularly during six weeks. Further investigation on the 
clinical usefulness of assessing MSH in relation to aeMSH, and to follow the change in the 
difference between aeMSH and MSH after intervention, is recommended for further research. 
6.2 MAXIMAL STEP-UP TEST (MST) AS A SELF-TEST 
People across the globe have vastly different opportunities for leading healthy lives. Wide-
spread changes in lifestyle over the last few decades that have meant reduced everyday 
physical activity – with increased sedentary behaviour, low aerobic fitness and low muscle 
strength as important consequences – have brought about many health risks for a very large 
number of people. Based on the findings presented in this thesis, and while awaiting further 
research to provide different easy-to-use functionality tests for routine testing of patients’ leg 
muscle strength – a perishable article! – we want to encourage clinical staff within both 
primary and specialised health care to try out the clinical benefits of MST on individual 
patients. We would also like to recommend that health care professionals teach their patients 
to use MST (on two steps of a flight of stairs, on a number of step-up boards on top of each 
other or on another everyday device) as a self-test for leg strength and leg functionality. This 
would enable patients themselves to react to differences in functionality between legs and to 
reduced strength and functionality in relation to age and weight, or after symptom-inducing 
osteoarthritis in the hip or knee, when detecting a decrease in MSH.   
 





In clinical practice, objective measurements of physical function are seldom used and routines 
are generally not in place. The maximal step-up test – assessing maximal step-up height on 
each leg – represents one aspect of current individual leg function, and is most likely 
dependent on leg muscle strength, but also on mobility, coordination, joint stability, balance 
and degree of pain.  
From this thesis is concluded that a maximal step-up test is simple to conduct, requires little 
equipment and space and can be performed by subjects in everyday clothing. We suggest that 
the maximal step-up test could be a useful and valid test of leg muscle strength and physical 
function and could be integrated into ordinary clinical routines. 
This new standardised maximal step-up test is robust and safe and maximal step-up height 
could be valuable as a relevant health indicator in clinical practice, not least when assessing 
patients of all ages in order to prescribe physical activity as treatment.  
A 3-month group exercise intervention significantly improved maximal step-up height, 
aerobic fitness and self-reported health, and decreased risk in female patients with reduced 
capacity to work, elevated cardio-metabolic risk and low self-reported health. At an average 
of 22-month follow-up investigation, when brisk walking was reported as the main exercise, 
the maximal step-up height was reduced to lower than baseline. However, significant positive 
effects remained for waist circumference, VO2 max, self-reported health, physical function as 
well as exercise and physical activity. Regular group exercise 2-3 times per week with mixed 
aerobic fitness and strength training, and with support from health care professionals, is 
probably needed to maintain improved leg muscle strength and function among these primary 
health care patients.  
However, regular group exercise 2-3 times per week with mixed aerobic fitness and strength 
training was associated with maintenance of maximal step-up height, whereas brisk walking 
for at least 150 minutes per week was not sufficient to maintain maximal step-up height in a 
subgroup of women. 
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Figur 4. Standardiserat maximalt klivhöjdstest (MST) – instruktioner på svenska  
 
Bild 1. Ena foten stadigt i golvet, den andra på brädan i klivlådan. Gå upp så högt som möjligt 
på tå med golvfoten, stå stilla och hitta balansen.  
Bild 2. Titta framåt, sträck på ryggen, för över kroppsvikten till klivfoten på brädan. Stå stilla 
och hitta balansen. 
Bild 3. Kliv långsamt upp utan att skjuta ifrån med golvfoten genom att pressa klivfoten mot 
lådan (brädan) samtidigt som överkroppen lutas lite framåt, därefter räta ut i knä och höft.  
Bild 4. Klivet avslutas med att golvfoten placeras på brädan tillsammans med klivfoten. 
Efter godkänt test höjs klivnivån tills den högsta godkända nivån nåtts. Tre försök på varje 
höjd är tillåtet. Testaren får gärna uppmuntra personen som testas under klivtestet. Högsta 
uppmätta klivhöjden (MSH) noteras för respektive ben och ett medelvärde för båda 
klivhöjderna kan användas för jämförelser och vid statistiska beräkningar. En låg maximal 
klivhöjd respektive sidoskillnad kan upptäckas.  
 
 
 
 
